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Multipotent skeletal progenitor cells that reside in the bone marrow and contribute to the
maintenance and repair of bone tissue are difficult to identify and, as a result, remain poorly
understood. Osterix is a zinc finger transcription factor, which functions as a key regulator of
bone formation. Cells of the osteoblast lineage generate bone tissue by depositing a mineralized
matrix [1, 2]. Osterix is selectively expressed in cells of the osteoblast lineage and has an
essential function in osteoblast commitment and bone formation [1, 3]. While it is generally
accepted that Osterix is expressed in early osteogenic precursors [3, 5-7], recent studies from our
lab and others have suggested that Osterix may be expressed at an even earlier stage of the
lineage, being present in a multipotent bone marrow skeletal progenitor cell population, which
can be expanded in vitro as a bone marrow mesenchymal stem cells (BMSCs).
To further explore the expression of Osterix in early bone marrow skeletal progenitor
cells, we have generated Osterix-Cherry reporter mice. Preliminary characterization of this
animal model suggests reporter expression accurately represents endogenous Osterix expression,
being largely restricted to skeletal tissues. Additionally, FACS isolation, replating, and
differentiation of Osterix-Cherry+ bone marrow derived stromal cells provide evidence of their
skeletal multipotency, indicated by their ability to differentiate into osteoblasts, adipocytes and
chondrocytes. Based on our preliminary data, we have formulated the following hypothesis:
Osterix expression identifies a multipotent bone marrow skeletal progenitor cell population.
The goals of my thesis will be to: (1) characterize Osterix reporter expression during
skeletal development and (2) characterize the bone marrow cell population expressing the Osterix
reporter gene.
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CHAPTER I: INTRODUCTION
THE REGENERATIVE CAPACITY OF BONE TISSUE
An increasing body of work provides evidence for the complex role of bone tissue
in a variety of physiological processes. Mechanically, the skeleton provides structural
support, protects delicate internal organs, allows for motion and movement, and even
allows for sound conduction in the inner ear. Metabolically, bone tissue is a critical
regulator of mineral homeostasis in that it is the primary site of calcium and phosphate
storage which is regulated in conjunction with bone resorption and new bone deposition
[6, 8-14].
Bone tissue
also has an amazing
capacity to
regenerate, whether
it involves the
mechanisms of
normal bone turnover
or injury induced
repair. Bone
FIGURE 1 : SCHEMATIC OF BONE FORMATION AND
RESORPTION
The mesenchymal stem cell gives rise to osteoblast precursors which differentiate into
osteoblasts, the bone forming cells of the skeletal system. The hematopoietic stem cell gives rise
to the osteoclast, which resorbs bone. [4]

remodeling occurs
throughout life. In this
process, mature bone
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tissue is resorbed and new bone tissue is laid down in the same place. The balance
between these processes controls for the reshaping of the skeleton and allows for the
repair of tissues following injury, such as overt fracture, but also in response to the
micro-damage that occurs during normal activity. Remodeling the skeleton also allows
for it to respond to mechanical loading. In the adult, approximately 10% of the skeleton is
remodeled per year [14].
In this regard, it is generally accepted that mesenchymal stem cells provide an
essential cellular source from which mature bone cells differentiate to support these
regenerative processes (Fig 1) [15, 16]. However, our knowledge of mesenchymal stem
cells or skeletal progenitor cells remains poorly understood. The focus of my thesis work
has been on increasing our understanding of bone marrow skeletal progenitor cells.

THE DISCOVERY OF BONE MARROW SKELETAL PROGENITORS
Bone marrow stromal cells (BMSCs) were first discovered by Friedenstein in
1966 [17] and further characterized by his group as a rare cell population within the bone
marrow that maintained skeletal potential [18]. Because of their skeletal potential and
their accessibility through bone marrow aspiration, the application of BMSCs for
therapeutic purposes has been the driving motivation to understand their biological
properties. However, because of their rarity within the bone marrow, multipotent skeletal
progenitors have remained a challenge to study in vivo and much of our understanding
has been ascertained after expansion in vitro. In this regard, BMSCs display selective
adherence to tissue culture plastic relative to most other hematopoietic cell types, retain
the capacity to self-renew, support hematopoiesis, and differentiate into a variety of
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connective tissue cell types, including the osteoblast, chondrocyte, and adipocyte[15, 19,
20] and are considered to be derived from a non-hematopoietic cellular component of the
bone marrow stroma [21].

WHAT ARE STROMAL CELLS? (CURRENT THINKING)
BMSCs are a subpopulation of cells within the marrow and are considered to be a
non-hematopoietic cellular component of the bone marrow stroma, with recent studies
suggesting that the BMSC may represent a subpopulation of reticular cells [21, 22]. More
recent studies have alluded to the potential identity and function of reticular cells within
the bone marrow. Reticular cells are a heterogeneous perivascular cell population located
adjacent to endothelial lined sinusoids within the bone marrow [23]. Reticular cells
function to support different hematopoietic events, including hematopoietic stem cell
retention and self-renewal and B-cell development [24, 25]. Selective isolation and
characterization of CD146+ bone marrow reticular cells from human tissue has also
revealed their BMSC-like properties [26, 27]. While mouse BMSCs do not express
CD146, Cxcl12+ and Nestin+ murine bone marrow perivascular cells also display
BMSC-like properties. Interestingly, human CD146+ reticular cells and murine Cxcl12+
and Nestin+ cells retain similar gene markers including Cxcl12, Stem Cell Factor (SCF),
and Angiopoietin 1. Surprisingly, these cells have also been shown to express Osterix [24,
27-29], which was previously considered to be a skeletally specific transcription factor.
Traditionally, the identity of various cell types within the bone marrow has been
characterized based on cell surface profiling. Cells which express CD45 or leukocyte
13

common antigen, are considered to be of the hematopoietic lineage[30], cells which
express CD11b are of the myeloid lineage [31], and cells which express CD31 are of the
endothelial lineage [32]. The exclusion of cells which are positive for any of these three
lineage markers has been used to narrow down the various cell populations within the
marrow, while other markers are being sought that will define the BMSC. In mice, three
specific markers have been shown to be expressed on the cell surface of putative BMSCs;
these markers include Sca-1 [33], CD44 and CD29 [34]. Multiple other markers are
currently being examined to try to find the one cell surface marker that defines a BMSC,
as seen in the human mesenchymal stem cell / reticular cell which is positive for CD146,
without luck.

ANATOMICAL ORGANIZATION OF THE BONE MARROW ENVIRONMENT
The organization of the bone marrow is a crucial clue to furthering our
understanding of the various cell types which reside in this heterogeneous environment.
The bone marrow is, indisputably, a complicated environment, consisting of many cell
types and it is very difficult to accurately and consistently delineate different cell types
within the stroma. The bone marrow itself largely consists of hematopoietic cells. With
this in mind, one might think the marrow environment is largely fluid, but that is not the
case. Fate mapping studies have shown that cells within the stroma do not move
throughout the compartment [35, 36], but they maintain a fixed position from embryonic
establishment throughout adult life [36].
Recent studies by Ding et al, have shown that different types of progenitor cells
occupy physically distinct niches within the bone marrow stroma. Hematopoietic stem
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cells (HSCs) occupy a perivascular niche whereas early lymphoid progenitors occupy an
endosteal niche [35]. This provides more evidence that the marrow is a highly organized
compartment, with a variety of cellular signals yet to be determined which are promoting
and maintaining different phenotypes in a variety of cells that are in close proximity to
each other. In this thesis the focus will be on osteoblasts and BMSCs which contribute to
the osteoblastic lineage only, as the identity of other cells within the marrow is still being
defined.

THE ORIGIN OF BONE MARROW SKELETAL STEM CELLS
ENDOCHONDRAL OSSIFICATION AND THE BONE MARROW COMPARTMENT
During embryonic development, bone tissue forms through two distinct processes
termed: intramembranous ossification and endochondral ossification. Most craniofacial
bones develop through intramembranous ossification where mesenchymal cells directly
differentiate into osteoblasts and osteocytes [10]. Mesenchymal condensations are
formed at the site of future bone development where the mesenchymal cells become
osteoblasts and produce bone matrix directly. The cells which become the craniofacial
skeleton are predominately derived from the cranial neural crest[37]. The axial and
appendicular skeleton develop through endochondral ossification, where mesenchymal
cells first condense and differentiate into chondrocytes to form a cartilaginous anlagen
[6]. These skeletal cells originate from the mesoderm[37]. This cartilaginous anlagen
serves as a template for bone formation as chondrocytes within the anlagen signal to the
outer perichondrium providing critical signaling cues that coordinate the growth and
differentiation of cartilage with bone [6]. There is generally very little marrow space in
15

bones which form through intramembranous ossification, whereas bones which form
through endochondral ossification have a large marrow compartment. [38].

FORMATION OF THE STROMA
Formation of the stroma occurs during chondrocyte maturation and is coordinated
with osteoblast differentiation. In the beginning of this process, signals secreted from
hypertrophic chondrocytes trigger vascular invasion. During embryonic endochondral
bone formation, factors secreted from the maturing growth plate chondrocytes initiate the
expression of Runx2 in the adjacent perichondrium. Runx2 is a transcription factor that is
considered to be at least one of the two master regulators of osteoblast differentiation.
Mice deficient for Runx2 completely lack bone tissue and gene markers of osteoblast
differentiation. Runx2 also turns on Osterix, another key transcription factor essential for
osteoblast differentiation. Interestingly, Osterix knockout animals express normal levels
of Runx2, however osteoblast differentiation remains impaired and no bone tissue forms.
Fate mapping studies have also provided evidence that perichondrial cells also
migrate into the developing bone marrow compartment during this time. Embryonic cells
which have been marked by Osterix fate mapping studies have been shown to populate
the bone marrow and differentiate into osteoblasts and osteocytes. The precursors which
form endochondral bone have been shown to come from a perichondrial origin. These
cells migrate into the bone marrow and subsequently contribute to the bone marrow
stroma [36, 39].
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Previous studies have also indicated a role for Osterix in the osteoblast lineage,
specifically in defining osteoblast commitment, but fate mapping studies have indicated
the Osterix fate mapped embryonic precursors were not restricted to the osteoblastic
lineage and instead contributed to many cell types within the bone marrow stroma. These
cells included perivascular stromal cells, vascular smooth muscle, bone marrow
adipocytes and perineural cells [36], indicative of the multipotency of this population.
After vascular invasion occurs, much of the outer cartilage is replaced by bone as blood
vessels further invade the epiphyses to form secondary ossification centers [40].

OSTERIX
Because of the important role of Osterix in early skeletal development, it merited
further study. Osterix is a Cys2-His2 type DNA binding zinc finger protein belonging to
the SP1 family of transcription factors. The protein itself contains three C2H2 zinc
fingers along with a nuclear localization signal, enriching the location of Osterix to the
nucleus. The mouse Osterix gene is found on Chromosome 15. The human homolog of
the mouse Osterix gene maps to 12q13.13. This is a three exon gene that encodes two
distinct spliceaforms. In humans, the first isoform is a 431 amino acid residue long
protein isoform and the second is an amino-terminus truncated short protein isoform.
Both isoforms are highly specific for osteoblasts, but some expression is seen in
chondrocytes as well [41, 42].
In Osterix global knockout mice, the initial establishment of a cartilaginous
skeletal template appears grossly normal, but osteoblast differentiation fails to occur,
leading to perinatal lethality [1]. More recently, conditional knockout studies have shown
17

that Osterix is not only required for embryonic bone formation, but also for the
maintenance of adult bone. Temporal inactivation of Osterix in postnatal and adult mice
using an inducible ubiquitous Cre results in the absence of osteoblasts on the bone
surface, severely altered bone structures, few mature osteoblasts and no Osteoid, leading
to substantially weaker bones [3]. Interestingly, the chondrocyte specific disruption of
Osterix, using a Col2a1-Cre, is also perinatal lethal. The in vivo patterning of
endochondral bone was impaired and delayed, with expanded hypertrophic zones and
significant reductions in chondrocyte specific gene markers in this model [43]. Taken
together these studies indicate that Osterix not only has a role in osteoblast differentiation
and maintenance, but is also necessary for chondrocyte differentiation [44].

USE OF FLUORESCENT REPORTER MICE TO STUDY SKELETAL
PROGENITOR CELLS
In this thesis, we have used fluorescent proteins to help us study skeletal
progenitor cells. Fluorescent proteins were first isolated from the jellyfish and cloned in
1992. They have since been modified to have different spectral characteristics. By 2009,
over 15,000 papers have used Green Fluorescent Proteins (GFPs) or their derivatives in
some form, and GFPs have been inserted into almost all laboratory species [45].
Fluorescent proteins make it much easier to track specific cells / cell types. As skeletal
development is such a complex process, the use of fluorescent proteins allows for the
tracing of various cells as development progresses.
In order to make the most use of fluorescent proteins we have used Bacterial
Artificial Chromosomes (BACs). BACs are vectors which hold large quantities (100-
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300kb) of DNA. These BACs often contain entire gene sequences as well as upstream
regulatory elements. The use of BAC transgenesis to create fluorescent reporter mice
involves homologous recombination and the insertion of a plasmid containing the GFP
color of interest[46]. By inserting a red GFP (Cherry) upstream of the translational start
site on the BAC clone and subsequent pronuclear injection, we have created a real-time
reporter mouse where Osterix expression is marked by a Cherry GFP. By using these
tools, we can compare the expression pattern of the reporter to that of endogenous
Osterix as well as cross these Osterix-Cherry reporter mice with other skeletally specific
lines that we have in house which utilize different spectrally distinct GFPs. This allows
us to more easily break down a complex process such as endochondral ossification into
its molecular parts.
Work by others and recent studies in our lab have suggested that Osterix
expression may occur earlier than appreciated being present in multipotent BMSCs [36,
39]. Therefore, because of the struggles that the field has with identifying a multipotent
BMSC, we have created and characterized an Osterix-Cherry Reporter mouse where
these potentially important cells are marked with a cherry fluorescent protein. Early
identification of a putative BMSC based on fluorescence and cell surface profiling will
allow for easier isolation. Since bone marrow isolates are currently being used in various
therapeutic applications, identifying the BMSC will hopefully lead to better clinical
outcomes/ increased therapeutic potential.
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CHAPTER II: SPECIFIC AIMS
Multipotent skeletal progenitor cells that reside in the bone marrow and contribute
to the maintenance and repair of bone tissue are difficult to identify and, as a result,
remain poorly understood. Osterix is a zinc finger transcription factor, which functions
as a key regulator of bone formation. Cells of the osteoblast lineage generate bone tissue
by depositing a mineralized matrix [1, 2]. Osterix is selectively expressed in cells of the
osteoblast lineage and has an essential function in osteoblast commitment and bone
formation [1, 3]. While it is generally accepted that Osterix is expressed in early
osteogenic precursors [3, 5-7], recent studies from our lab and others have suggested that
Osterix may be expressed at an even earlier stage of the lineage, being present in a
multipotent bone marrow skeletal progenitor cell population, which can be expanded in
vitro as a bone marrow mesenchymal stem cells (BMSCs).
To further explore the expression of Osterix in early bone marrow skeletal
progenitor cells, we have generated Osterix-Cherry reporter mice. Preliminary
characterization of this animal model suggests reporter expression accurately represents
endogenous Osterix expression, being largely restricted to skeletal tissues. Additionally,
FACS isolation, replating, and differentiation of Osterix-Cherry+ bone marrow derived
stromal cells provide evidence of their skeletal multipotency, indicated by their ability to
differentiate into osteoblasts, adipocytes and chondrocytes. Based on our preliminary
data, we have formulated the following hypothesis:
Osterix expression identifies a multipotent bone marrow skeletal progenitor cell
population.
20

AIM 1: TO CHARACTERIZE THE EXPRESSION OF OSTERIX REPORTER MICE
DURING SKELETAL DEVELOPMENT
Temporal analysis of Osterix reporter expression will be carried out at embryonic,
post natal and adult ages. Reporter expression will first be grossly examined
macroscopically followed by a more detailed characterization in tissue section. In this
analysis, Osterix reporter mice will also be intercrossed with previously generated
osteoblast reporter mouse models to aid in its characterization. Osterix reporter
expression will also be compared to endogenous gene expression by immunostaining on
tissue sections, as well as through FACS isolation of Osterix+ and negative cells
followed by RT-PCR.

AIM 2: TO DETERMINE IF OSTERIX+ BONE MARROW CELLS REPRESENT A
MULTIPOTENT SKELETAL PROGENITOR CELL POPULATION.
Osterix+ bone marrow cells will be characterized to determine their identity, selfrenewal and multipotent properties. Cell surface profiling and gene expression analysis
will be carried out to assess the mesenchymal stem cell-like profile of Osterix+ bone
marrow cells. Colony forming unit assays will be carried out to determine their selfrenewal capacity. Also, in vitro differentiation assays and transplantation will be used to
assess the skeletal potency of Osterix+ bone marrow cells.
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CHAPTER III: MATERIALS AND METHODS
DNA CONSTRUCTS AND ANIMAL CARE
BAC clone RP24-362M3 was obtained from the Children’s Hospital Research
Institute (CHORI). The BACLinkSP linking vector was generously provided by Claire
Huxley [47]. The pLD53-SC2 and pSV1.RecA recombination vectors were generously
provided by Shiaoching Gong [48]. The mini lambda vector was generously provided by
Donald M. Court [49]. Transgenic animals were housed in a clean barrier facility and
humanely treated in accordance with University of Connecticut Health Center
institutional guidelines. The Osterix-Cherry transgenic mouse line will become available
to the research community upon acceptance of this manuscript.
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CLONING HOMOLOGY ARMS INTO THE BAC LINKING VECTOR
All homology arms were amplified using Phusion DNA Polymerase (New
England BioLabs) in a C1000 Thermal Cycler (BioRad). An overlapping PCR scheme
was used to simultaneously clone homology arms flanking the Osterix gene into
BACLinkSP. For this, homology arm 1 (A1) was amplified using oligos 5’Arm1OLPCR
(sense) 5’AGCTAAGGCTGGGCTTTCTTGATTTGTCTGGTGTGCATGCACCACCATGCCCA
GTGACAA-3’ and 3’Arm1Mlu (antisense) 5’CTTCACGCGTCACTAACAAACGCTTCTATAATCCTTAC-3’ which contained an
Mlu1 site. Homology arm 2 (A2) was amplified using 5’Arm2BamH1 (sense) 5’CTCTGGATCCGAGGGAGGAGGATCTTGACCAGCATCA-3’ which contained a
BamH1 site and 3’ OLPCRArm2 (antisense) 5’TTGTCACTGGGCATGGTGGTGCATGCACACCAGACAAATCAAGAAAGCCCAG
CCTAGCT-3’. PCR amplified homology arms were run out on a 1% agarose gel and gel
purified using a Zymoclean Gel DNA Recovery Kit (Zymo Research). The purified PCR
products were eluted in 10 ul of water and diluted 1:10 in water and combined into a
single tube. To promote annealing of the overlapping region, homology arms were
heated to 95°C and a seven minute cool down was implemented followed by thermal
cycling (95°C - 55°C - 72°C) for 25 cycles. After 25 cycles, 5’ Arm2BamH1 or 3’
Arm1Mlu1 primers were added to the reaction and the reaction was allowed to proceed
for an additional 20 cycles. The resultant band was gel purified, restriction endonuclease
digested with BamH1 and Mlu1, and cloned into the BamH1 and Mlu1 sites of
pBACLinkSP using conventional cloning practices to create BACLinkSP-A1/A2.
23

SUBCLONING INTO BACLINKSP-A1/A2 TO CREATE BACLINKSP-OSTERIX

The Red Recombinase System was introduced into RP24-362M3 containing
DH10B cells by electroporation of a mini lamda vector [49-52]. Transformants were
selected on Chloramphenicol (12.5 ug/ml) plus tetracycline (10 ug/ml) LB agar plates
and grown at 30°C. RP24-362M3 and mini-lambda-containing DH10B cells were made
electrocompetent. Prior to harvesting cells to make them electrocompetent, bacteria were
grown at 30°C and heat shocked at 42°C for 15 minutes to activate the Red Recombinase
System.
To subclone the Osterix gene into BACLinkSP-A1/A2, XhoI was used to digest
BACLinkSP-A1/A2 and expose the ends of homology arms 1 and 2. The linearized
vector was then electroporated into RP24-362M3 and mini-lambda containing cells and
selected for on LB agar plates containing Spectinomycin (50 ug/ml). Recombinants were
screened by colony PCR with five separate primer pairs. Two primer pairs were
designed to flank homology arms A1 and A2. Primer pairs flanking homology arm 1
were: Ost 5’Arm1Recom (sense) 5’-CTACATGATGATTCAGAACCATCTGTAACT3’ and Belo2658 (antisense) 5’-TTTGTCACAGGGTTAAGGGC-3’. Primer pairs
flanking homology arm 2 were Ost 3’Arm2Recom (antisense) 5’CAGACAAATCAAGAAAGCCCAGCCTTAGCT-3’ and SP2 sense 5’GCCCTACACAAATTGGGAGA-3’. The three remaining primer pairs amplified
different regions within the Osterix subclone region and were used to confirm that the
entire region was transferred. These three primer pairs were OstSub5’T1 (sense) 5’TGGTCCAAGCCTGTGGACCAAGAAGCA-3’ and OstSub3’T1 (antisense) 3’24

AGGAACCACCTACTGAGAGGTGGCTAT-5’; OstSub5’T2ig (sense) 5’TCATAATGTTTCCGTGTCACCATC-3’ and OstSub3’T2ig (antisense) 3’TGCATGCGCTCTTGTGCATATGTACAT-5’; OstSub5’T3 (sense) 5’CTTAGCAGACACATACCCGAGGATGA-3’ and OstSub3’T3 (antisense) 3’ACTGAGTCCTCTGCACCAGTTGTAAG-5’. BAC subclones positively identified by
colony PCR were then further verified by Not1 and Mlu1 restriction endonuclease
digestion followed by field inversion gel electrophoresis.
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HOMOLOGY ARM CLONING INTO PLD53 TO CREATE PLD53-CHERRYOSTERIX
A 462 base pair homology arm located just upstream of the second translational
start site of Osterix was inserted into a pLD53.SC2-Cherry vector using standard cloning
practices. The homology arm was PCR amplified using Phusion DNA polymerase using
the RP24-362M3 BAC as a template. Primers Ost5’Asc1 (sense) 5’CTCTGGCGCGCCGTAGCTGAGGATGACCTGAGGTTC-3’ and Ost3’Sma1
(antisense) 3’-CTCTCCCGGGGACTGGAGCCATAGTGAGCTTCTTC-5’ were used to
amplify the homology arm. Amplified products were run through a PCR clean up
column (Qiagen) to reduce unincorporated nucleotides, then restriction endonuclease
digested with AscI and SmaI for three hours. The pLD53.SC2-Cherry vector was also
restriction endonuclease digested with AscI and SmaI for three hours. After digestion,
the homology arm was gel purified using a Zymoclean Gel DNA Recovery Kit (Zymo
Research). The pLD53.SC2-Cherry vector was briefly treated with calf intestinal
alkaline phosphatase (New England BioLabs) followed by a 1:1 phenol: chloroform
extraction and precipitation. Vector and insert were mixed and ligated at room
temperature for an hour using Quick Ligase (New England BioLabs) followed by
electroporation into competent PIR2 cells. Bacteria were allowed to recover for a half
hour before selection. Possible clones were selected for on LB plates containing
ampicillin (50 ug/ml) and identified by colony PCR screening followed by diagnostic
restriction endonuclease digestion with AscI and SmaI.
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REPORTER GENE INSERTION TO CREATE BACLINKSP-OSTERIX-CHERRY
In preparation for reporter gene insertion into BACLinkSP-Osterix, 50 ng of
pSV1.RecA was transformed into DH10B cells containing BACLinkSP-Osterix. After
transformation, bacteria were allowed to recover for one hour without antibiotic selection
followed by selection on LB agar plates containing Spectinomycin (50 ug/ml) and
tetracycline (10 ug/ml) at 30°C overnight. DH10B cells containing BACLinkSP-Osterix
and pSV1.RecA were made electrocompetent.
pLD53.SC2-Cherry-Osterix (1 ug) was electroporated into 50 ul of
electrocompetent bacteria containing the pSV1 vector and BACLinkSP-Osterix. Bacteria
were grown in 1 ml of LB without antibiotic selection for 1 hour at 30°C. 5 ml of LB
media containing Spectinomycin (50 ug/ml), Ampicillin (50 ug/ml) and Tetracycline (10
ug/ml) were then added to the electroporated cells and the culture was grown overnight at
30°C. 200 ul of the overnight culture was spread on to an agar plate containing
Spectinomycin (50 ug/ml) and Ampicillin (50 ug/ml) and grown at 42 °C overnight.
Colonies were picked and screened using primers that flanked the homology arm;
OsterixRecom (sense) 5’-GCCATCACACCAAGCCTGCTTTGTGT-3’ and
CherryGenotype (antisense) 5’-GCACCTTGAAGCGCATGAACTCCTTGATGA-3’.
Potential BACLinkSP-Osterix-Cherry clones which were positively identified by PCR
were then further verified by diagnostic restriction endonuclease digestion followed by
field inversion gel electrophoresis.
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PREPARATION OF BACLINKSP-OSTERIX-CHERRY FOR PRONUCLEAR
INJECTION
Verified BACLinkSP-Osterix-Cherry clones were grown and purified from 200
ml of bacterial culture using a Maxi kit (Qiagen) with minor modifications detailed here.
After alkaline lysis 2M potassium acetate was used in place of the standard 3M solution.
QF buffer was heated to 65 °C for elution and the column eluate was further cleaned up
with a 1:1 phenol: chloroform extraction followed by a chloroform extraction. 10 ug of
the purified BACLinkSP-Osterix-Cherry was linearized with a SalI restriction enzyme
digest and further purified on a Sepharose CL-4B column (Sigma) that had been
equilibrated with injection buffer (10 mM Tris pH 7.5, 0.1 mM EDTA, 100 mM NaCl).
Ten 200 ul fractions were collected and the DNA was quantified using a Nanodrop
spectrophotometer (Thermo Scientific). 30 ul of each fraction was run on a pulse field
gel to assess DNA quality. Pronuclear injection was carried out at the UCONN Health
Center Gene Targeting and Transgenic Facility (GTTF).
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HISTOLOGICAL PREPARATION OF TISSUE SAMPLES
Selected tissues were dissected and fixed in 10% Formalin buffered in PBS for 4
days at 4 °C. Hind limbs from two week old or older mice were decalcified in 15%
EDTA for 4 to 7 days, depending on animal age. Tissues were then placed in 30%
sucrose overnight and finally embedded in Cryomedia (Thermo Scientific). Frozen 7 um
sections were obtained using a Leica Cryostat and Cryofilm type II tape transfer system
(Section-Lab Co. Ltd.). Sequential tissue sections were mounted using 50% glycerol
buffered in PBS for imaging.
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MICROSCOPY AND IMAGING
Whole mount images of embryonic animals and kidneys were taken using a Zeiss
SteREO Lumar V.12 fluorescent microscope at 9.6X and 15.4X magnification using
Cherry (HQ577/20 Ex, HQ640/40 Em) and EYFP (ET500/20 Ex, ET535/30 Em) filter
sets (Chroma Technologies) and photographed with an Axiocam MRm digital camera
(Zeiss). Exposure times were adjusted for optimum imaging, and kept consistent
throughout the experimental time course.
Tissue sections and cultures were imaged on a Zeiss Observer Z.1 microscope
using Cherry (HQ577/20 Ex, HQ640/40 Em, Q595lp beam splitter), EYFP (HQ500/20
Ex, HQ 535/30 Em, Q515lp beam splitter), DAPI (AT350/50x Ex; ET460/50m Em,
T400lp beam splitter) filter sets (Chroma Technologies). In some cases, the same tissue
section was then stained with Mayer’s hematoxylin (Poly Scientific) and photographed
using an Axiocam MRc and digital camera (Zeiss) also on the Zeiss Observer Z.1
microscope.
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IMMUNOSTAINING FOR ENDOGENOUS OSTERIX
Tissue sections were dried for 30 minutes at room temperature and then
rehydrated by rinsing in PBS for 15 minutes. Sections were then permeabilized for 30
minutes in 0.1% Triton X-100 (Sigma) at room temperature. Afterwards, sections were
washed twice for 10 minutes in PBS at room temperature. Non-specific staining was
blocked with a 1% BSA and 5% goat serum solution (Invitrogen) in PBS for one hour.
The blocking solution was removed, and the section was incubated in an Osterix rabbit
polyclonal IgG primary antibody (Santa Cruz Biotechnologies A-13, sc-22536) at a
1:2000 dilution in 1% BSA and 1% goat serum in PBS overnight at 4 °C. Tissue sections
were then washed three times at 10 minutes per wash in PBS. Tissue sections were then
suspended in a solution containing the secondary antibody, goat anti-rabbit Alexa Fluor
488 (Invitrogen) at a 1:500 dilution in 1% BSA and 1% goat serum in PBS. Tissue
sections were incubated with the secondary antibody at room temperature in the dark for
two hours. Sections were then washed three times for ten minutes each in PBS and
mounted on slides in 50% PBS-buffered glycerol for imaging.
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HARVESTING AND FACS ISOLATION OF PRIMARY CELLS FROM CALVARIA
AND LONG BONE
Five to seven day old mice were sacrificed and dissected to obtain their skulls and
hind limbs. Soft tissues were grossly removed with a scalpel and calvaria and hind limb
long bones were placed in ice cold PBS. Cells were enzymatically digested from bone
tissue in a solution containing 0.625 mg/ml Collagenase P (Roche) and 0.01% Trypsin
EDTA (Invitrogen) in PBS. Bone tissues were initially digested for 15 minutes in a 37°C
shaker, and the supernatant from the first digestion was discarded. Three subsequent
digestions were carried out for 20 minutes each. Cells from these three digestions were
pooled, run through a 70 µM strainer, centrifuged at 300 x g and resuspended in 49%
PBS, 49% OPTI-MEM (Gibco) and 2% FBS. Prior to FACS sorting, cells were filtered
again through a 5 ml round bottom 40 µM cell strainer capped FACS tube (Falcon) and
kept on ice. FACS isolation was carried out using a Vantage SE FACS sorter (BD
Biosciences) at the University of Connecticut Health Center Flow Cytometry Facility.
Cells were collected in 20% serum in a 1:1 mixture of OPTI-MEM (Gibco) and PBS on
ice.
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RNA EXTRACTION
A Nucleospin RNA/Protein Kit (Macherey-Nagel) was used to extract the RNA
from sorted cell populations. In brief, cells were lysed in RA1 buffer containing Bmercaptoethanol. The resultant mixture was filtered through a column, in which the cell
lysate was cleared. Ethanol was added to the filtrate and the mixture was spun through a
second column, where the RNA binds to the column matrix and proteins flow through.
The column membrane was desalted and then the DNA was digested, yielding a pure
RNA sample in the column. The column was then washed twice with ethanol and eluted
in 40 ul of RNase-free water. RNA concentrations were measured with a Nanodrop
spectrophotometer (Thermo Scientific).
RNA was extracted from kidneys at different ages. Isolated kidneys were placed
in Trizol (Invitrogen) and homogenized. Following the chloroform extraction, RNA was
further purified through consecutive 1:1 phenol: chloroform extractions until the interface
between aqueous and organic layers appeared clean. Samples were then chloroform
extracted and precipitated in isopropanol. RNA pellets were washed in 75% ethanol and
resuspended in DEPC treated water. RNA concentrations were measured with a
Nanodrop spectrophotometer (Thermo Scientific) and RNA integrity was confirmed by
gel electrophoresis.
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CDNA SYNTHESIS

RNA samples were first treated with DNAse I (Invitrogen) for 15 minutes at room
temperature to remove possible genomic DNA contamination. 25 mM EDTA
(Invitrogen) was added to each sample and samples were incubated at 65 °C for 10
minutes to inactive DNAse I. A master mix containing first strand buffer, random
primers, DTT, and dNTPs were added to each sample. Samples were then incubated for
10 minutes at 65 °C followed by incubation on ice. RNaseOUT recombinant
ribonuclease inhibitor (Invitrogen) and M-MLV reverse transcriptase (Invitrogen) were
added to each tube. Samples were mixed and incubated at 37°C for 1.5 hours, and then
the M-MLV was heat inactivated at 85 °C for 10 minutes.
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PCR AMPLIFICATION FOR OSTERIX MRNA ISOFORMS
mRNA isoform specific primers were designed using Vector NTI software
(Invitrogen) and the NCBI database / Primer-BLAST. mRNA1 was selectively amplified
using primer sets: Exon1-2 5’ (sense) 5’-TTCTCTCCATCTGCCTGACTCCTT-3’,
Exon1-2 3’ (antisense) 5’- CCATTGGTGCTTGAGAAGGGAGCTG-3’. mRNA2 was
selectively amplified using primer sets: Exon2 5’ (sense) 5’AGGCCACCCATTGCCAGTAA-3’, Exon 2 3’ (antisense) 5’GTCATTTGCATAGCCAGAGGCTGG-3’. PCR amplification was also carried out for
the Cherry reporter gene: Cherry2 5’ (sense) 5’-CATCCCCGACTACTTGAAGC-3’ and
Cherry2 3’ (antisense) 5’- CTTCAGCTTCAGCCTCTGCT-3’ and GAPDH: GAPDH5’
(sense) 5-CATGTTCCAGTATGACTCCACTC-3’ and GAPDH3’ (antisense) 5’GGCCTCACCCCATTTGATGT-3’. PCR amplification was carried out using standard
methodologies using a C1000 Thermal Cycler (BioRad).
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MAINTENANCE OF ANIMALS
Osterix-Cherry mice were generated by Sara Strecker [53]. Transgenic animals
were housed in a clean barrier facility and humanely treated in accordance with
University of Connecticut Health Center institutional guidelines. BSP transgenic mice
were generated by Peter Maye [54]. Mice were cared for by the Center of Animal Care
(CLAC) at the University of Connecticut. Mice were monitored twice weekly by
veterinary technicians. The Gene Targeting and Transgenic Facility (GTTF) injected the
BAC DNA construct into the mouse. If mice showed signs of stress, they were
euthanized. Adult mice were sacrificed using CO2 inhalation and subsequent cervical
dislocation, as published by CLAC. Neonatal mice were sacrificed via hypothermia
followed by decapitation. The animal protocol used is 2010-605.
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IMAGE ANALYSIS
The image analysis of the cortical sections was completed with the assistance of
Max Villa at the University of Connecticut, Storrs, CT. Briefly, a Euclidean Distance
Analysis was performed on multiple fluorescent images of cortical sections using the
Image J program (NIH, [55]). The inner cortical surface was selected and a region of
interest was generated. The image was converted to grayscale and a Euclidean Distance
Map was generated where a white (value 0) pixel was at the center of the marrow and a
black (value 255) pixel was the cortical edge. The rest of the image was coded such that
the distance from the center to the edge was repented by different grayscale values. A
duplicate of the original florescent image was then converted to a binary image. The
distance information for the Euclidean Distance Map was combined with the binary
image and a histogram was calculated, which showed the number of Cherry+ pixels as a
function of distance from the endocortical surface[56, 57].
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ALKALINE PHOSPHATASE STAINING

Two stock solutions were created at a concentration of 50mg/ml. Fast Blue BB 4benzoylamino-2, 5-diethoxybenzenediazonium chloride hemi [zinc chloride] salt (Sigma)
was dissolved in dimethyl formamide. NAMP 3-hydroxy-2-naphthoic acid 2, 4dimethylanilide phosphate (Sigma) was dissolved in dimethyl sulfoxide. Both stock
solutions were stored at -20°C.
Staining solutions were prepared immediately prior to use. An SB8.2 solution,
containing 0.1M Tris, pH 8.0, 50mM MgCl2, 100mM NaCl and 0.1% Tween20 was
prepared. Stock solutions were diluted in the staining solutions separately, such that each
staining solution contained 500ug/ml of either Fast Blue or NAMP. The staining
solutions were mixed together in equal parts and immediately applied to the tissue
section. Sections were stained for 3 minutes, rinsed in PBS and immediately coverslipped with a 50% Glycerol, 50% PBS mixture. Staining can be visualized as blue or
imaged under the Cy5 (ET620/60x Ex, ET700/75m Em, T660lpxr beam splitter) filter.
Osterix- Cherry was imaged under the Cherry (HQ577/20 Ex, HQ640/40 Em, Q595lp
beam splitter) filter.
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IMMUNOSTAINING FOR CD31
Tissue sections were dried for 30 minutes at room temperature and then
rehydrated by rinsing in PBS for 15 minutes. Sections were then permeabilized for 30
minutes in 0.1% Triton X-100 (Sigma) at room temperature. Afterwards, sections were
washed twice for 10 minutes in PBS at room temperature. Non-specific staining was
blocked with a 5% donkey serum solution in PBS for one hour. The blocking solution
was removed, and the section was incubated in a CD31 (R&D Systems AF3628) at a 1:20
dilution in 1% donkey serum in PBS overnight at 4 °C. Tissue sections were then
washed three times at 10 minutes per wash in PBS then suspended in a solution
containing the secondary antibody, donkey anti-goat Dylight 488 (Jackson Immuno
Research Labs, 705-486-147) at a 1:3500 dilution in 1% donkey serum in PBS. Tissue
sections were incubated with the secondary antibody at room temperature in the dark for
two hours. Sections were then washed three times for ten minutes each in PBS and
mounted on slides in 50% PBS-buffered glycerol for imaging.
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PREPARATION OF BONE MARROW STROMAL CELLS FOR CULTURE AND
SORT

Osterix-Cherry mice were used both for cell surface profiling directly from the
marrow and to derive BMSC cultures. In brief, 3-4 week old mice were sacrificed by CO2
asphyxiation followed by cervical dislocation. Femurs and tibia were dissected from the
surrounding tissues. The bones were cut through the mid-diaphysis and the bone marrow
was collected through centrifugation. In brief, eppendorf tubes, each containing a filterless column, were prepared. 200 ul of sterile cold PFE (98% PBS, 2% FBS, 2 mM
EDTA) were added to the bottom of the eppendorf tube. Bones were placed, cut side
down into the column and spun at high speed for 3 minutes. Single cell suspensions were
prepared by gently mixing the cells with a pipette followed by filtration through a 70 μm
strainer. Cells which were to be analyzed immediately were subjected to a red blood cell
lysis. For the red blood cell lysis, the cells were pelleted by spinning for 5 minutes at
350g and 1 ml of Red Blood Cell Lysing Buffer (Sigma, R7757) was added to the pellet.
This was gently mixed for one minute than placed on ice for three minutes. The Red
Blood Cell Lysing Buffer was diluted with 10 ml of PBS and then the cells were
centrifuged at 350g for 7 minute. The supernatant was decanted and the cells were
prepared for further profiling.
Cells which were to be cultured did not undergo Red Blood Cell Lysis and were
plated at a density of 1.2 × 106 cells/cm2 in αMEM culture medium containing 100 U/ml
penicillin, 100 μg/ml streptomycin and 10% FCS (Hyclone). At day 4, the media was
changed. On day 5, the cells were sorted and processed. In some cases, cells were
cultured for a 21 day time period. In these cases, cells were grown in αMEM culture
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medium containing 100 U/ml penicillin, 100 μg/ml streptomycin and 10% FCS
(Hyclone) for 7 days, with the media being changed on Day 4 and Day 7. On Day 7, the
media was supplemented with 50 μg/ml ascorbic acid and 8 mM 2-glycerol phosphate
and changed every two days until Day 21.
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FACS ANALYSIS
Cultured cells were washed twice with cold PBS then digested using a sterile
filtered mixture of 0.1% Collagenase P (Roche), 0.1% Hyaluronidase (Sigma), 2% FBS
(Hyclone), 49% OPTI-MEM (Gibco) and 49% PBS (Gibco). Cells were digested for 10
minutes at 37°C, scraped, then digested for an additional 5 minutes at 37°C. The
digestion was stopped using an equal amount of media containing 2% FBS, 49% PBS
and 49% OPTI-MEM. At this point, cultured cells and cells from the marrow were
treated in the same manner. Cells were counted and then centrifuged at 300g for 10
minutes. Up to 107 nucleated cells were resuspended in 100 ul FACS staining buffer
(PBS, 0.5% BSA, 2 mM EDTA, pH 7.2). 10 ul of the appropriate antibody was then
added to the cell suspension. This was mixed well and incubated for 10 minutes in the
dark at 4 °C. Next the cells were washed by the addition of 1-2 ml of buffer and
subsequent centrifugation at 300 g for 10 minutes. The supernatant was aspirated and the
cells were resuspended in 500 ul of staining buffer for FACS analysis.
Antibodies used were all conjugated to APC in order to be spectrally distinct from
the Cherry and included CD11b (Miltenyi, 130-091-241), CD31 (Miltenyi, 130-097-420),
CD45 (Miltenyi, 130-091-811), CD44 (Miltenyi, 130-096-836), CD140b (Miltenyi,
130-096-270) CD105 (Miltenyi, 130-092-930), Anti-Sca1 (Miltenyi, 130-093-223),
CD29 (Miltenyi, 130-096-356) and CD90.2 (Miltenyi, 130-091-790). Cells were
analyzed on the FACS LSRII (BD) using the Red 649 nm Laser (670/30) and the YS 561
nm Laser (610/20, 600LP). The Blue 488 nm Laser (530/30, 505LP) was sometimes used
to gate out auto-fluorescent cells.
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FACS SORTING
Cells from the bone marrow were sorted using the 70 um nozzle on the FACS
Aria (BD). Cells which had been cultured were also sorted on the FACS Aria, however
the 130 um nozzle was used. Cells were sorted for mCherry using the Green Laser
(610/20, 600LP), APC using the Red Laser (660/20) and GFP using the Blue Laser
(530/30, 505LP). Cells were originally sorted into media containing 20% FBS
(Hyclone), 40% PBS (Gibco) and 40% OPTI-MEM (Gibco). However, our current
research is suggesting that the cells remain viable for a longer period of time if they are
sorted into media containing 2% FBS (Hyclone), 49% PBS (Gibco) and 49% OPTIMEM (Gibco), therefore, sorts conducted in Chapter I were sorted into 20% serum
containing media and sorts conducted in Chapter II were sorted into media containing 2%
serum.
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DIFFERENTIATION OF ISOLATED CELL POPULATIONS
After FACS, isolated cell populations were initially plated as a spot with
~ 2 × 104 cells in 10 μl of medium (αMEM culture medium containing 100 U/ml
Penicillin, 100 μg/ml streptomycin and 10% FCS (Hyclone)) for osteogenic and
adipogenic differentiation. 2 × 106 cells were plated in a 10 ul spot for chondrogenic
differentiation. After 2 hours, αMEM culture medium containing 100 U/ml penicillin,
100 μg/ml streptomycin and 10% FCS (Hyclone) was added to the spot cultures.
Osteogenic differentiation was induced with the addition of 50 μg/ml ascorbic acid, and
8 mM 2-glycerol phosphate to the culture media on Day 1 and cells were maintained in
differentiation media for 8 days. Adipogenic differentiation was induced with the
addition of 1.0 uM insulin and 0.5 uM Rosiglitizone to the culture media on Day 1 and
cells were maintained in differentiation media for 8 days. Chondrogenic differentiation
was induced on Day 1. Cells were cultured in high glucose DMEM which was
supplemented with ITS+1, 50 μg/ml ascorbic acid, 100 μg/ml sodium pyruvate, 0.1 uM
dexamethasone, 100 U/ml penicillin, 100 μg/ml streptomycin, 40 μg/ml L-proline and 10
ng/ml TGF-Β3.
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HISTOLOGICAL EVALUATION OF ISOLATED CELL POPULATIONS
Osteogenesis was assessed through von Kossa staining. Cultures were washed
with PBS then fixed in 10% formalin for 10–15 min. Cultures were next rinsed with
water and a 5% silver nitrate solution was added. Cross-linking to evaluate the amount of
phosphate deposition was performed for 2 cycles at 1200 µjoules × 100 in a UV
Stratalinker (Stratagene, La Jolla, CA). Mineralized nodules appear as dark spots.
Cultures counterstained with Mayer’s Hematoxylin.
Adipogenesis was assessed through Oil Red O staining. In brief, cultures were
washed in PBS and fixed for 10 minutes in 10% formalin. After fixation, cultures were
washed with water and air dried. The 0.5% stock Oil Red O solution was diluted to
0.3%, filtered through Whatman #1 filter paper, and then added to the dry cultures. This
was incubated for 1 hour at room temperature and the stain was aspirated. Cultures were
washed twice with water and counterstained with Mayer’s Hematoxylin.
Chondrogenesis was assessed through Alcian Blue staining. Cultures were rinsed
with PBS then fixed with 10% formalin for 10 minutes. Cultures were then briefly rinsed
with a solution of 3% glacial acetic acid (pH 1.0). Alcian blue staining was carried out
overnight using a 1% Alcian Blue solution (pH 1.0).

Excess staining was removed

through a wash in 3% glacial acetic (pH 1.0) and then two washes with 3% glacial acetic
acid (pH 2.5).
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CHAPTER IV: GENERATION AND CHARACTERIZATION
OF OSTERIX-CHERRY REPORTER MICE
See Appendix for Copyright

ABSTRACT
Osterix is a zinc finger containing transcription factor and functions as a key
regulator of osteoblast differentiation. To better understand the temporal and spatial
expression of Osterix during embryonic development and in the adult skeleton, we
generated Osterix-Cherry reporter mice. Bacterial recombination techniques were
employed to engineer a transgenic construct, which consisted of a ~39kb DNA fragment
encompassing the Osterix/Sp7 gene, but excluding adjacent gene sequences. Osterix
reporter expression was characterized at embryonic, neonatal, and adult ages both by
itself and in the context of a cross with Bone Sialoprotein (BSP)-Topaz reporter mice.
Relative to Osterix, BSP is a more mature marker of osteoblast differentiation. In
agreement with osteoblast lineage maturation, Osterix reporter expression preceded BSP
reporter expression during embryonic development and spatially appeared in a much
broader cell population. Strong Osterix reporter expression was observed in mature
osteoblasts and osteocytes. However, weaker Osterix-Cherry+ cells were also observed
in the bone marrow, possibly identifying an early osteoprogenitor cell population.
Evaluation of Osterix reporter expression in male femur tissue sections from 10 days to
12 weeks of age revealed persistent expression in cells of the osteoblast lineage and a
surprising increase in maturing chondrocytes of the growth plate. Also, Osterix reporter
expression was transiently detected in the kidney after birth.
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INTRODUCTION
Bone development occurs through two different processes termed
intramembranous ossification and endochondral ossification [6, 58-60]. Most bones of
the craniofacial skeleton develop through intramembranous ossification, where
mesenchymal cells directly differentiate into cells of the osteoblast lineage. However, in
the axial and appendicular skeleton, all bones develop through endochondral ossification,
in which mesenchymal cells first condense and differentiate into chondrocytes that form
cartilaginous anlagen. The cartilaginous anlagen serves as a physical template for bone
formation and chondrocytes within the anlagen signal to the outer perichondrium,
providing critical signaling cues that coordinate the colonization/replacement of cartilage
by bone.
Genetic studies in mice have revealed that Osterix is a key transcriptional
regulator of osteoblast differentiation and, more recently, of chondrocyte maturation.
Osterix is a Cys2-His2 type zinc finger protein that binds DNA and belongs to the SP1
family of transcription factors [1]. In Osterix global knockout mice, the initial
establishment of a cartilaginous skeleton appears grossly normal, but osteoblast
differentiation fails to occur, leading to perinatal lethality [1]. Global inactivation of
floxed Osterix at postnatal and adult ages using Cag-CreER mice resulted in loss of
osteoblasts on the bone surface and progressive deterioration of bone tissue, revealing
that Osterix continues to have an essential role in maintaining bone tissue at adult ages
[3]. Selective deletion of Osterix with Col2a1-Cre has also revealed an important role for
Osterix in chondrocyte maturation. Loss of Osterix in chondrocytes resulted in an

47

expanded hypertrophic zone that failed to completely mature, resulting in a significant
delay and reduction in vascular invasion and bone remodeling by osteoclasts [43].
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RESULTS
To increase our understanding of Osterix gene expression at embryonic and adult
ages, we generated Osterix-Cherry reporter mice. The Osterix gene is located in a
relatively gene rich area on mouse chromosome 15. Therefore, in designing the
transgene, we decided to separate Osterix from these neighboring genes by subcloning a
39kb DNA fragment containing the Osterix gene using a bacterial recombination
approach (Fig.2A). This subcloned DNA fragment includes 24457 bp of sequence
upstream of the first translational start site and ends 6920 bp downstream of the stop
codon. To verify the isolated region‘s identity, Not1 and Mlu1 restriction endonuclease
digests were carried out. Two predicted bands, one at approximately 22 kb and the
second at 25 kb were observed, thereby identifying three positive clones (Fig. 2B). Work
by others [2, 41] and our own alignment of mRNA transcripts deposited into the NCBI
database have shown that Osterix transcription yields two alternatively spliced mRNAs.
mRNA1 encodes for a slightly larger 428 amino acid isoform whose translation starts in
exon 1, while mRNA2 encodes for a shorter 410 amino acid isoform whose translation
starts in exon 2 (Fig. 2C). The second downstream translation start site is in frame with
the upstream translation start site. Therefore, we decided to insert a Cherry fluorescent
protein reporter just upstream of the second translation start site in order to detect both
Osterix isoforms (Fig.2C, red arrow head). To confirm the targeted insertion of the
Cherry reporter, colony PCR was carried out using primers that flank the 462 bp
homology box (Fig. 2D). Pronuclear injection of the DNA construct resulted in
generation of two different founder lines. Gross evaluation of reporter gene expression
from F1 and F2 offspring from both founder lines showed identical expression patterns
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(data not shown). Thereafter, we have primarily focused on one founder line and present
a more detailed characterization of its reporter gene expression here.

FIGURE 2: ASSEMBLY OF OSTERIX-CHERRY TRANSGENE
(a) A 39 kb region containing the Osterix gene and flanking DNA sequences was subcloned from BAC clone RP24-362M3 into
BACLink-SP. (b) Potential subclones were confirmed by a diagnostic restriction endonuclease digestion with Mlu1 and Not1, which
showed two DNA fragments at 25 and 22 kb. (c) Diagram of the Osterix gene (black) mapped with two alternatively spliced mRNA
transcripts (blue). Two alternative translational start sites also exist. The first translational start site is located in exon 1b and results in
the creation of a long protein isoform (mRNA1) consisting of 428 amino acids. The second translational start site is located near the
beginning of exon 2, is in frame with the upstream translational start site, and results in the creation of a shorter protein isoform
(mRNA2) consisting 410 amino acids. The Cherry reporter was inserted via homologous recombination just upstream of the second
translational start site of the Osterix gene (red arrow) allowing us to detect both transcriptional isoforms. (d) Gel image of colony PCR
screening to identify clones where the Cherry reporter was appropriately inserted into the construct. Two positive clones are shown.

To aid in the characterization of Osterix-Cherry mice, we compared their reporter
expression to that of a Bone Sialoprotein (BSP)-Topaz reporter mouse line [54]. During
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osteoblast differentiation, Osterix expression precedes BSP and is required for BSP
expression [61]. The BSP –Topaz reporter line utilizes a fluorescent protein that is
spectrally distinct from Cherry fluorescent protein, allowing us to simultaneously image
both reporters and visualize immature and mature osteoblast cell types. Osterix-Cherry
reporter expression (red) was characterized relative to BSP-Topaz reporter expression
(green) from days E13.5 to E17.5 of embryonic development. Congruent with skeletal
development occurring asynchronously in an anterior to posterior progression, Osterix
reporter expression was first detected at E13.5 in craniofacial bones and weakly in the
fore limbs (Fig. 3A). BSP reporter expression was also detected at E13.5 (Fig. 3B);
however the domains of Osterix reporter expression were noticeably broader than those
of the BSP reporter (Fig. 3 Compare A to B, and C). At E15.5, Osterix reporter
expression increased relative to E13.5 and now can be detected in the ribs and hind limbs
(Fig. 3D). Levels of BSP reporter expression have also increased from E13.5 to E15.5
and globally appear in the same regions as Osterix (Fig.3 E and F). The progression of
osteoblast maturation can be appreciated at higher magnification in the frontal and
parietal bones of the skull (Fig.3 G-I) and the radius, ulna, and humerus of the fore limb
(Fig.3 J-K). Again, the domains of Osterix reporter expression are broader than those
controlled by BSP and show the transition from osteoprogenitor to a maturing osteoblast.
Both Osterix and BSP reporters at this age are osteoblast specific and do not appear in
other connective tissue cell types such as the sutures of the skull (Fig.3 G-I) or in joints of
the appendicular skeleton (Fig.3 J-L). At E17.5 the expression levels of Osterix and BSP
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FIGURE 3: COMPARISON OF
OSTERIX REPORTER EXPRESSION
TO BONE SIALOPROTEIN
(a–o) Whole embryo imaging of
reporter gene expression from E13.5–
E17. (a ,d, g, j, m) Osterix-Cherry
reporter expression (red). (b, e, h, k, n)
Bone Sialoprotein – Topaz reporter
expression (green). (c, f, i, l, o) Merge
of Osterix and Bone Sialoprotein
reporter expression yellow indicates
where the signals overlap). (a–c)
Comparison of Osterix and Bone
Sialoprotein reporter expression at
E13.5 (a) Osterix reporter expression is
first detected at E13.5 in the developing
craniofacial bones and in the fore limbs.
Very weak Osterix reporter expression
is detected in the developing hind
limbs. (b) The onset of Bone
Sialoprotein reporter expression is also
detected at E13.5. (c) The merged
image confirms the overlap between
both osteoblast reporter models;
however, the Osterix reporter is
expressed in a considerably broader cell
population than the Bone Sialoprotein
reporter. (d–i) Comparison of Osterix
and Bone Sialoprotein reporter
expression at E15.5. (d) Levels of
Osterix reporter expression have
increased relative to E13.5 and are now
easily detected in the hind limbs and
ribs in addition to the bones of the
craniofacial skeleton and fore limb. (e)
Levels of Bone Sialoprotein reporter
expression have also increased since
E13.5 and appear in the same skeletal
elements as the Osterix reporter as
shown in the merged image (f).
While both reporter genes are expressed
in the same skeletal elements, the
broader cellular expression of the
Osterix reporter relative to the Bone
Sialoprotein reporter is apparent and
appreciated at higher magnification in
the skull (g–i) and fore limb (j–l). (m–
o) Osterix and Bone Sialoprotein
reporter expression at E17.5. Osterix
reporter expression is now detected in
the vertebrae and developing digits,
whereas the Bone Sialoprotein reporter
is seen in the spine, but has not yet
appeared in the metatarsals.

reporters continued to increase (Fig.3 M-O). Osterix and BSP reporters are now detected
in the vertebrae and pelvic girdle. Also, as limb development progresses in a proximal to
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distal fashion, Osterix reporter expression is detected in the digits of the paws (Fig.3 MO).

FIGURE 4: COMPARISON OF OSTERIX REPORTER EXPRESSION TO BONE SIALOPROTEIN REPORTER EXPRESSION IN A
TISSUE SECTION THROUGH A 3-WEEK-OLD FEMUR.
(a) Merged image of Osterix-Cherry (red) and Bone Sialoprotein-Topaz (green) reporter expression. Global visualization of reporter
expression revealed that the Osterix reporter is intensely and uniformly expressed in osteoblasts within the trabecular and cortical bone
regions. In contrast, Bone Sialoprotein reporter expression was not as uniformly expressed as the Osterix reporter and appeared at
higher levels within the trabecular bone region and at lower levels in cortical bone. This is better appreciated at higher magnification
[regions of interest are denoted by dashed boxes (b–d) and (e–g)]. (b and e) Osterix reporter expression was strongly expressed in
osteoblasts and osteocytes within trabecular bone (b) and cortical bone (e). Low Osterix reporter expression was also detected in a cell
population present in the bone marrow, but in proximity to trabecular and cortical bone surfaces. (c and f) Bone Sialoprotein reporter
expression was strongly detected in osteoblasts and osteocytes in the trabecular bone region (c), but was expressed at lower levels and
appeared with less frequency in osteoblasts and osteocytes present in cortical bone (f). Unlike the Osterix reporter, the Bone
Sialoprotein reporter was not detected in any cells within the bone marrow. (d and g) Merged images reveal the expression of both
reporters relative to each other in the trabecular and cortical bone regions.

Characterization of Osterix-Cherry reporter expression was also compared to BSP-Topaz
reporter expression in tissue sections through a 3 week old femur (Fig. 4). The whole
femur was imaged for both reporters (Fig. 4A) and areas of trabecular bone (Fig. 4B-D)
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and cortical bone (Fig. 4E-G) are shown at higher magnification. Osterix reporter
expression was robustly and broadly expressed in cells of the osteoblast lineage (Fig.
4A). Strong Osterix reporter expression is present in mature osteoblasts lining trabecular
and cortical bone surfaces and osteocytes embedded within bone tissue (Fig. 4, A, B, and
E). In contrast, BSP reporter expression is not nearly as uniform as the Osterix reporter.
High levels of BSP reporter expression were detected just below the growth plate within
the trabecular bone region (Fig. 4 A and C), but gradually decreased as the distance from
the growth plate increased, with lower BSP reporter expression being present in
osteoblasts on the cortical bone surfaces in the mid-diaphysis region (Fig. 4 compare C to
F). Also, the frequency of BSP+ cells was higher on the endosteal bone surfaces relative
to the outer periosteum (Fig. 4 F and not shown). In addition to the Osterix reporter
being strongly expressed in osteoblasts and osteocytes, we also noted the detection of a
bone marrow cell population situated in proximity to bone surfaces that retained lower
Osterix reporter expression (Fig. 4 B and E). The BSP reporter was not detected in this
bone marrow cell population (Fig. 4 C and F), suggesting this may be a very early
osteoprogenitor cell type.
Loss of function studies at postnatal to adult ages have indicated that Osterix
continues to play an essential role in the maintenance of bone tissue [7, 44, 62, 63].
Consistent with these studies, the evaluation of Osterix reporter expression in male
femurs at increasing ages (10 days, 3 weeks, 8 weeks, and 12 weeks) suggests that
Osterix expression persists in cells of the osteoblast lineage into adulthood (Fig. 5).
Interestingly, in this temporal analysis we also detected an increase in Osterix reporter
expression in maturing chondrocytes of the growth plate. In three week old animals,
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FIGURE 5: STRONG AND PERSISTENT OSTERIX REPORTER EXPRESSION IN BONE CELLS WITH AGING.
Osterix reporter expression and corresponding hematoxylin stained tissue sections at postnatal day 10 (a, a’) 3 weeks (b, b’), 8 weeks
(c, c’), and 12 weeks of age (d, d’). Osterix reporter expression persisted with aging in osteoblasts and osteocytes present in the
trabecular and cortical bone regions. Fixed exposure times were used and all femurs were taken from male mice.

expression of the Osterix reporter was very weak in the growth plate relative to the level
of reporter gene expression detected in the bone cells (Fig. 6A). However, by 8 weeks of
age, Osterix reporter expression was easily detected in maturing chondrocytes (Fig. 6B)
and at twelve weeks of age, the area of the growth plate retaining Osterix reporter
expression was arguably the highest expressing region within the bone (Fig. 6C).
FIGURE 6: INCREASE IN OSTERIX REPORTER EXPRESSION IN GROWTH PLATE
CHONDROCYTES WITH AGING
(a–c) A fixed exposure time was used to compare the fluorescence intensity of Osterix
reporter expression in growth plate chondrocytes at 3 weeks (a), 8 weeks (b), and 12
weeks of age (c). While the Osterix reporter can be detected in growth plate
chondrocytes in 3-week-old mice (a), there is a substantial increase in reporter
expression detected in 8-week-old mice (b), which continues to increase with age as
shown in 12-week-old mice (c).

To determine if expression of the Osterix reporter
represents endogenous Osterix gene expression, we
compared Osterix reporter expression to endogenous
levels of Osterix protein by immunostaining.
Immunostaining for Osterix was initially carried out
directly on bone tissue sections derived from Osterix transgenic mice. However, we soon
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learned that the polyclonal antibody that worked extremely well in our hands recognized
our reporter gene. The reason for this is that we cloned into the second exon, just
upstream of the second translational start site, in order to detect both transcriptional
isoforms. In doing so, transcription and translation of mRNA1-Cherry results in the
creation of a small protein fusion in which the first 17 amino acids of Osterix are present
on the N-terminal of the Cherry reporter. Correspondence with Santa Cruz
Biotechnologies confirmed that the

FIGURE 7: COMPARISON OF OSTERIX REPORTER EXPRESSION TO IMMUNOSTAINING FOR OSTERIX PROTEIN
Osterix reporter expression (red) was compared with immunostaining for Osterix protein (green) in tissue sections of 4-week-old
femurs [tissue sections were counterstained with DAPI (blue)]. Comparison of expression was assessed in four different regions: (a, b)
cortical bone, (c, d) trabecular bone, (e, f) growth plate cartilage, and (g, h) articular cartilage. Osterix reporter expression was highly
expressed in osteoblasts lining the cortical (a, white arrows) and trabecular bone surfaces (c) and osteocytes embedded in bone tissue
(a). Immunostaining also revealed high levels of Osterix protein expression in osteoblasts lining cortical (b, white arrows) and
trabecular bone surfaces (d), but was difficult to detect in osteocytes (b). (e) Osterix reporter expression was broadly expressed at low
levels in growth plate chondrocytes with slightly higher levels of reporter expression present in maturing chondrocytes. (f)
Immunostaining reveals Osterix protein was largely restricted to chondrocytes undergoing hypertrophy. At the end of the distal femur,
Osterix reporter expression (g) and immunostaining for Osterix (h) correlate well in the articular cartilage as shown by overlapping
signals in chondrocytes undergoing hypertrophy. (BM, bone marrow; CB, cortical bone; PS, primary spongiosa; SS, secondary
spongiosa).
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polyclonal antibody (A-13) was raised against this region of Osterix and therefore
selectively detects the long protein isoform of Osterix. Unfortunately, many other
antibodies against Osterix were tried, but did not work well in our hands. Alternatively,
we decided to use the A-13 antibody on non-transgenic littermates and compare
immunostaining (green fluorescence) to Osterix reporter expression (red fluorescence)
(Fig. 7). Tissue sections were counterstained with DAPI (blue fluorescence). Four
different regions of interest within the femur were compared; cortical bone (Fig. 7,
compare A to B), trabecular bone (Fig. 7, compare C to D), the growth plate (Fig. 7,
compare E to F), and the articular surface at the distal end of the femur (Fig. 7, compare
G to H). In the cortical and trabecular bone regions, Osterix reporter expression appeared
strongest in osteoblasts lining the bone surface (white arrows), but also had fairly high
levels of expression in osteocytes within the bone tissue (Fig. 7 A and C). Consistent
with Osterix reporter expression, immunostaining for Osterix was most intense in
osteoblasts lining the cortical (white arrows) and trabecular bone surfaces, whereas
noticeably less protein was detected in osteocytes (Fig. 7 B and D). As detailed earlier,
Osterix reporter expression increased with age in maturing chondrocytes within the
growth plate (Fig. 6). However, by four weeks of age and relative to osteoblasts and
osteocytes, the Osterix reporter is expressed at lower levels in chondrocytes of the growth
plate, with slightly higher levels being present in maturing chondrocytes (Fig. 7E). In
contrast, immunostained Osterix protein was only detected in chondrocytes undergoing
hypertrophy (Fig. 7E). Unlike the differences observed between reporter and
immunostaining in the growth plate, Cherry expression correlated well with
immunostaining in articular chondrocytes. In the knee joint, Osterix reporter expression
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is absent from the most superficial zones of the articular surface in the distal femur, but
appears in maturing chondrocytes further away from the articular surface (Fig. 7G, white
arrows). In a similar manner, detection of Osterix protein was also present in maturing
chondrocytes below the articular surface (Fig. 7).
While Osterix immunostaining largely correlated with Osterix reporter gene
expression, some differences were observed. Possible reasons for these differences may
FIGURE 8: GENE EXPRESSION ANALYSIS OF OSTERIX MRNA
ISOFORMS ON FACS ISOLATED PRIMARY CELLS
Primary cells were harvested from the calvaria and hind limb of
Osterix reporter mice at postnatal day 5 and FACS isolated for gene
expression studies. (a–d) FACS isolation of Osterix positive (P5orange) and negative (P4-purple) cell populations from calvaria (a)
and hind limb (c). (b, d) Nontransgenic littermate controls are also
shown. (e) Gene expression analysis was carried out for the Cherry
reporter gene, both transcriptional isoforms of Osterix (mRNA1 and
mRNA2) and GAPDH. Both transcriptional isoforms are detected in
the Cherry positive cell fraction, while mRNA2 was also weakly
detected in the negative cell fraction.

relate to the fact that the reporter should reflect
the expression of both transcriptional isoforms
of Osterix, while the A-13 polyclonal antibody
only recognized the long protein isoform.
Additionally, post-transcriptional mechanisms
that would regulate levels of Osterix protein
would not be reflected in reporter gene
expression.
To further compare expression of the Osterix reporter to endogenous Osterix, we
also carried out RT-PCR on reporter positive and negative cell populations that were
isolated by FACS from neonatal calvaria and long bones (Fig. 8, A-D). Approximately
50% of the cells digested out of the calvaria (Fig. 8A) and 12% of the cells digested from
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long bones (Fig. 8C) were Osterix reporter positive. RT-PCR was carried out on the
reporter (Cherry), the individual isoforms of Osterix (mRNA1 and mRNA2), and GAPDH
(Fig. 8E). Amplification for the Cherry reporter confirmed that FACS dramatically
enriched for the Osterix reporter positive and negative cell populations. Specific
amplification for both alternative isoforms of Osterix revealed that mRNA1 was
exclusively expressed in the reporter positive cell population, while mRNA2 could be
detected in both cell fractions with higher levels being present in the reporter positive cell
fraction.
While expression of the Osterix reporter was largely restricted to skeletal tissues,
we also detected high levels of reporter expression for a transient period of time in the
kidneys of newborn pups that gradually decreased by the time animals were weaned (Fig.
9). To further characterize renal Osterix reporter expression, kidney samples were
collected from transgenic mice at E17.5 (Fig. 9A), P4 (Fig. 9B) and 3 weeks (Fig. 9C) of
age and the intensity of fluorescent reporter expression was compared. Surprisingly, at
E17.5 and 3 weeks, reporter expression was detectable, but very weak, while reporter
expression at P4 was extremely high. We also examined Osterix reporter expression in 6
week and 11 week old transgenic animals, but no reporter expression was detected (data
not shown). Further examination of Osterix reporter expression in tissue sections of P4
animals (Fig. 9, D, E, E’, E’’) revealed that reporter expression was present in the
juxtamedullary nephrons, which are located in the cortex, but adjacent to the medulla
(Fig. 9D). Within the juxtamedullary nephrons, Osterix reporter expression was detected
at low levels in the proximal convoluted tubules and at higher levels in the thick
descending limb of the loop of Henley (Fig. 9, E’ and E”).
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FIGURE 9: TRANSIENT OSTERIX REPORTER EXPRESSION IN THE KIDNEY
(a–c) Detection of Osterix reporter expression (red) in kidneys harvested from E17.5 (a), post-natal day 4 (P4) (b), and 3 week old (c)
animals reveals the transient nature of reporter gene expression. (d, e, e’, e’’) Imaging of Osterix reporter expression in kidney tissue
sections at P4. (d) Scanned image of a coronal section revealing Osterix reporter expression (red) in the juxtamedullary nephrons
(purple-hematoxylin counterstaining). (e’, e’’) Reporter expression seen at high magnification from a region of interest shown in (d)
revealing expression in the proximal convoluted tubule and the thick descending limb of loop of Henle. (f) Analyses of endogenous
Osterix transcription showed that only mRNA2 was transiently detected in the kidney, while expression of mRNA1 was not detected.

To determine if Osterix is expressed transiently in the kidney, RT-PCR was carried out
on transgenic positive and negative kidney samples at E17.5, P4, and 3 weeks of age
(Fig. 9F). Interestingly, we were able to detect only one of the two isoforms in the
kidney, mRNA2. Also, expression of the mRNA2 isoform was transient, similar to that
observed with our reporter gene. For reasons that remain unclear to us, we had a very
difficult time detecting mRNA for the Cherry reporter in the kidney at P4, near the time
point where we are able to visualize robust fluorescent expression.
In this study, we have described the transgene assembly and expression of an
Osterix-Cherry fluorescent reporter mouse model. Characterization of reporter
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expression suggests that the 39kb transgene largely retains many of the cis regulatory
elements necessary for regulating Osterix gene expression in skeletal tissues from
embryonic to adult ages. Consistent with Osterix having an essential role in osteoblast
and chondrocyte development, Osterix reporter expression was largely restricted to both
of these skeletal lineages. However, we have also noted transient reporter expression in
the kidney that was particularly strong at neonatal ages. Given the timing of reporter
expression in the kidney in relation to lactation, it is intriguing to speculate that perhaps
Osterix may have a role in regulating mineral homeostasis during this period of active
skeletal growth and development.
The transgenic reporter was designed to detect both transcriptional isoforms of
Osterix. Other groups have reported on the existence and expression of both Osterix
isoforms, however, there is disagreement with regard to which isoform may be the
predominant form, if any. Milona et al. have reported that the shorter isoform (mRNA2)
is more highly expressed in skeletal cell types [41], while Nishio et al. provided evidence
that the longer isoform (mRNA1) predominates [2]. Our immunostaining studies, which
have utilized an antibody that recognizes the long protein isoform of Osterix, clearly
indicate that mRNA1 is highly expressed in osteoblasts and hypertrophic chondrocytes.
However, analyses of isoform specific transcripts by RT-PCR on FACS isolated cell
populations indicate that both transcriptional isoforms are likely to be expressed in a
relatively skeletal specific manner with perhaps mRNA2 being expressed at significantly
lower levels in non-skeletal cell types. It remains unclear if any functional differences
exist between either protein isoform of Osterix.

61

One of the significant advantages of fluorescent protein reporter mice is that they
provide investigators with the means to isolate and study intrinsically labeled cell
populations. Work by us and others have generated a variety of different fluorescent
reporter mice to study the osteoblast lineage [54, 64-66]. As a critical mediator of
osteoblast commitment, Osterix has a very early and pivotal role within the osteoblast
lineage. Supporting this thinking, the onset of Osterix-driven Cherry expression
appeared earlier and in a broader cell population than BSP reporter expression during
embryonic development. We also observed a low Osterix reporter expressing cell
population in the bone marrow that was also BSP reporter negative, which may mark a
very early osteoprogenitor required for supporting postnatal skeletal growth and bone
maintenance. Therefore, Osterix reporter mice may provide us with a means to isolate
and study the earliest cells of the osteoblast cell lineage, which still remain poorly
understood.
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CHAPTER V: DEFINING THE OSTERIX-CHERRY+
MESENCHYMAL PROGENITOR WITHIN THE BONE
MARROW
ABSTRACT:
In this study, we have investigated the identity and biological properties of a bone
marrow cell population retaining low Osterix reporter expression. Histological
examination of reporter expression in bone tissue cross-sections revealed that bone
marrow cells retaining low Osterix reporter expression were situated in proximity to
endocortical bone surfaces and not uniformly distributed throughout the marrow.
Immunostaining for the endothelial cell surface marker CD31 showed that approximately
40% of the Osterix reporter cells associated with the vascular sinusoids, but were not
endothelial cells. Stromal cultures derived from Osterix-reporter mice showed that
cherry+ cells flushed from the marrow attached to tissue culture plastic and expanded in
culture. Furthermore, the in vitro differentiation of day 5 sorted Osterix-reporter cells
along the osteoblast, chondrocyte, and adipocyte cell lineages provided evidence for their
uncommitted multipotent skeletal potential. Additionally, during osteoblast
differentiation, Osterix reporter expression dramatically increased supporting the belief
that low Osterix reporter expression identifies an early skeletal progenitor. By FACS
analysis, ~2% of the bone marrow retained cherry reporter fluorescence. Cell surface
profiling on the bone marrow fraction indicated that the bone marrow cell population
retaining Osterix reporter expression was very heterogeneous in nature being 60%
positive for CD31, 60% positive for CD11blow, and ~85-90% positive for CD45low, CD44
and CD29. Surprisingly, few Osterix reporter expressing bone marrow cells were
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positive for known mesenchymal cell markers Sca1, CD105, and CD140b, with the
exception of CD90.2. However after culturing for five days, Osterix-Cherry cells adopted
a mesenchymal cell profile by dramatically increasing in Sca1, CD105, and CD140b, but
retained the hematopoietic cell surface markers CD45 and CD11b.
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INTRODUCTION:
Our knowledge of bone marrow skeletal progenitor cells remains limited. Work
by Friedenstein provided the first evidence that skeletal progenitor cells exist in the bone
marrow and could be extracted and expanded in culture. This cell population was present
at a low frequency inside the bone marrow, was adherent to tissue culture plastic,
appeared fibroblast-like in cell morphology, retained skeletal potential and supported
hematopoiesis [18]. Work by many other groups have substantiated Friedenstein’s work
[19, 20, 67] and cell culture remains the easiest way to enrich and expand for these
skeletal progenitors. Because of their skeletal potential and accessibility through bone
marrow aspiration, the application of these cells for therapeutic purposes has supported
great research efforts to further define the identity and biological properties of these cells.
The in vivo identity of the cells which establish the hematopoietic environment in
bone marrow has not been well defined [27]. In humans, CD146+ sub-endothelial cells
have shown to be clonogenic upon transplantation, however, a similar marker in mice has
not been determined[26, 27]. CD146+ sub-endothelial cells reside on the vascular
sinusoidal network within the marrow. These cells produce large quantities of
Angiopoietin-1 and are involved in the vascular remodeling of the sinusoidal network
[27]. Other cell types have also been shown to have a role in the hematopoietic
microenvironment. CAR cells, which are multipotent progenitor cells, also express
cytokines necessary for the homing and maintenance of hematopoietic stem cells in the
bone marrow and b-cell development, including CXCL12 and Stem Cell Factor
(SCF)[24]. Another cell type within the hematopoietic niche is the Nestin+ reticular cell
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[29, 68], which has been shown to be multipotent and which has also been shown to
express Osterix [69].
Osterix is a zinc finger transcription factor, which functions as a key regulator of
osteoblast differentiation [1, 2]. Osterix is selectively expressed in cells of the osteoblast
lineage and has an essential function in osteoblast commitment and bone formation [1, 3].
While it is generally accepted that Osterix is expressed in early osteogenic precursors [3,
5-7], our understanding regarding the plasticity of these precursors for the osteoblast
lineage relative to other cell lineages is lacking. However, recent fate mapping studies
using Osterix-Cre mice have provided evidence that Osterix expression occurs in early
uncommitted skeletal progenitor cells that contribute to a variety of cell lineages inside
the bone marrow[70].
To better understand the early skeletal progenitor cell types retaining Osterix
expression, we recently generated Osterix-Cherry reporter mice. Previous studies from
our lab and others have used fluorescent reporter mice to aid in defining cells of the
osteoblastic lineage [71, 72]. Inside the bone marrow of this animal model is a cell
population retaining low Osterix reporter expression (LORE) that in many ways is
morphologically reminiscent of a reticular cell population. Here we provide evidence
that LORE cells represent a very early skeletal progenitor retaining multipotent skeletal
potential.
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RESULTS:
LORE CELLS ARE LOCATED NEAR THE ENDOSTEAL BONE SURFACE AND ARE
ASSOCIATED WITH VASCULAR SINUSOIDS
The location of cells within the bone marrow stroma is proving to be a very
important indicator of possible cellular function. Past characterization of Osterix-Cherry
reporter mice showed strong reporter expression in mature osteoblasts and
osteocytes[53]. Relative to the robust reporter expression in mature osteoblasts and
osteocytes, we also noted a low Osterix reporter expressing cell population present within
the bone marrow compartment that we have referred to as LORE cells.

FIGURE 10: DISTRIBUTION OF OSTERIX-CHERRY+ CELLS IN THE BONE MARROW
(a) Cherry positive cells are seen in the periphery of the cortical bone, when the bone is cut in cross section (blue arrows) (b) High
Magnification of the cortical bone, showing Cherry+ cells (blue arrows) appear predominantly near the endocortical surface with few
positive cells appearing near the central region of the marrow. (c) Distribution pattern of Osterix-Cherry+ cells as assessed by Image J
(representative graph); much of the Cherry+ cells appear adjacent to, or within the first 20% of the marrow radially, near the
endocortical surface.

To better elucidate the location of these cells within the marrow, we sectioned
long bones derived from Osterix-Cherry reporter mice in a longitudinal plane and in
cross-section. As seen in the cross-section taken from the mid-diaphysis of a three week
old femur, these cells seem to congregate near the endocortical surface (Fig 10 A, B high
mag, blue arrows). There are very few LORE cells near the center of the marrow. The
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LORE cells appear to be within the first few cell layers, under 100µm from the
endocortical surface. This can also be seen if the bone is cut in a longitudinal section
close to the endocortical surface (data not shown). Multiple sections were cut in the
transverse plane and were analyzed to determine the distribution of the Osterix-Cherry+
cell in the marrow. The analysis showed that all of the Osterix-Cherry+ cells were
located in a ring which included about 20% of the radius of the marrow space, near the
endocortical surface (Fig 10C).
Many LORE cells morphologically appeared similar to bone marrow reticular
cells, containing thin dendritic like processes. Along these lines, sub-endothelial
perivascular stromal cells, which associate with the bone marrow vascular sinusoids have
been shown to display skeletal potential [73]. Therefore, we carried out CD31
immunostaining to visualize the location of bone marrow endothelial cells to OsterixCherry+ cells. Immunostaining showed that a subpopulation of LORE cells were
associated with the vascular sinusoidal network (Fig 11 A-C).
Based on our analysis of our immunostaining (and subsequent FACS) we knew
that not all of the CD31+ cells were Cherry+, nor were all Cherry+ cells positive for
CD31. However, we felt that it was likely that Osterix-Cherry cells were associating
with CD31+ endothelial cells(Fig 11).
We also looked at Alkaline Phosphatase (ALP) staining using a set of reagents
that was spectrally distinct from our Cherry reporter. ALP staining marked many of the
Osterix-Cherry+ dendritic cells, especially those close to the endocortical surface (Fig 11
D-F).
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FIGURE 11: CD31 IMMUNOSTAINING AND ALP STAINING IN
THE MARROW
(a) Section of the bone marrow of a 3 week old mouse, showing
GFP reporter expression for Osterix Cherry (b) Same section of
the marrow, showing immunostaining for CD31, marking the
sinusoids within the marry. (c) Osterix-Cherry and CD31 staining
overlay, showing the association of the Osterix cherry positive cells
(Red) with the CD31+ (Green) sinusoidal network. Approximately
40% of the Cherry+ cells associate with CD31+ vascular sinusoids.
(d) Section of the bone marrow from a 7 week old mouse, showing
Osterix Chery expression. (e) ALP fast blue staining for Alkaline
phosphatase showing the dendritic nature of ALP positive cells (f)
Osterix-Cherry and ALP staining overlay, showing the ALP staining
(Green) surrounding the Osterix-Cherry positive cells (Red) near
the endocortical surface. Scale bars are all 20um.

EXAMINATION OF OSTERIX REPORTER EXPRESSION IN BONE MARROW
STROMAL CULTURES
Given the detection of LORE cells inside the bone marrow, stromal cultures were
carried out to determine if and how well LORE cells contributed to the overall adherent
stromal cell population. By FACS roughly 1-2% of the total cell population from the
flushed bone marrow retained Osterix reporter expression (Fig 12J). Osterix reporter
labeled cells were imaged at progressive stages of culture during growth and osteogenic
differentiation. In the heterogeneous environment of the stromal culture, we noted 24
hours after plating that a small subpopulation of fluorescent cells attached to tissue
culture plastic, established a mesenchymal cell morphology, and were organized in small
colonies of cells (Fig 12 A). For reasons that are not clear, some cell colonies persisted
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in culture, while others did not. At days 3 and 4 of culture, reporter gene intensity
decreased (Fig 12 A-D). However, after the addition of osteogenic inducing agents at
day 7, the intensity of Osterix reporter expression noticeably increased (Fig 12 compare E
to F). By day 14 of culture, strong Osterix reporter expression can be detected in
colonies defining putative regions of mature osteoblast differentiation (Fig 12F). By day
21, Osterix reporter expression was even brighter and correlated with areas of
mineralization detected by von Kossa (Fig 12 compare G to H).

FIGURE 12: OSTERIX-CHERRY EXPRESSION CHANGES DURING DIFFERENTIATION
(a-d) Early culture progression from 24 hours after plating (Day 1) to Day 4. Osterix Cherry expression gets more diffuse and weaker
at the early stages of culture, though the number of cells which are Osterix-Cherry+ continues to increase. The weakening trend
reverses at Day 5, at which point the cells increase in intensity through the culture period (e-i) Established culture progression up
through Day 21 of osteogenic differentiation. Osterix Cherry expression continues to increase as the culture progresses (e-g) Days 7,
14 and 21 of culture showing weaker Osterix-Cherry colonies spread throughout the plate, which increase at Day 14 and further
increase at Day 21. Exposure times are consistent (h) Von Kossa staining of a Day 21 culture, showing that areas of mineralization
correlate with areas of strongest Osterix-Cherry expression (i) FACS analysis shows the percentage of stromal cells isolated from the
marrow are Cherry + up through Day 21 of the culture period (j) FACS analysis showing the percentage of Osterix-Cherry+ cells in
the flushed bone marrow

We also quantified the percentage of cells retaining cherry fluorescence protein
by FACS. At day 0, approximately 2% of the cells isolated from the bone marrow are

70

Cherry+. This increased substantially by day 4, with approximately 30% of the cells
becoming Cherry+ (data not shown). By day 7, close to 50% of these cells are positive
for Osterix-Cherry and by day 21, when the culture is actively mineralizing,
approximately 80% of the total cells in the culture are Cherry+ (Fig 12I).

LORE CELLS RETAIN MULTIPOTENT SKELETAL POTENTIAL
To further characterize the stromal cell population retaining Osterix reporter
expression, we carried out in vitro differentiation studies. For these studies, the Osterix
reporter labeled cell population was FACS sorted from day 5 stromal cultures, replated in
culture, and differentiated along the osteoblast, adipocyte, and chondrocyte cell lineages.
In vitro differentiation was assessed by using histological staining to detect mineral
deposition (Fig. 13C), von Kossa), lipid vesicle formation (Fig. 13G, Oil Red-O), and
proteoglycan production (Fig.13K, Alcian blue). Gene expression analyses were also
carried out on days 0, 5 and 8 (osteoblast and adipocyte cultures) or days 0, 7 and 14
(chondrocyte cultures) to assess differentiation (Fig.13 D, H, L).
Not surprisingly, sorted Osterix reporter labeled cells efficiently differentiated
into bone. During osteoblast differentiation, Osterix reporter expression substantially
increased (Fig.13A and previously shown in Fig12), mineralization was visible under
DIC optics (Fig 13B) and by von Kossa staining (Fig 13C). During osteoblast
differentiation, mRNA levels of Bone Sialoprotein (BSP), Osteocalcin, and Dentin
Matrix Protein (DMP1) also dramatically increased.
Sorted Osterix labeled cells also retained the capacity to differentiate into
adipocytes. During adipocyte differentiation, reporter expression decreased substantially
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FIGURE 13: MULTIPOTENCY OF THE
OSTERIX-CHERRY+ POPULATION BY
HISTOLOGY AND GENE EXPRESSION
Sorted cell populations were plated as a
micromass and induced to differentiate into bone
(a-d), fat (e-h) and cartilage (i-l). The
morphological changes can be visualized
through fluorescence microscopy (a, e, i) and
DIC optics (b, f, j). Histological staining was
performed for mineralized matrix (c), fat
deposition (g) and proteoglycans (k). Cells
were collected from these micromass cultures at
early, middle and late time points and various
bone (d), fat (h) and cartilage (l) genes were
characterize by qPCR. Cultures derived from
Osterix-Cherry positive cells show a robust
increase in lineage specific genes

in cells that developed large lipid vesicles, while mesenchymal cells located around
forming adipocytes maintained Osterix reporter expression. Changes in cell morphology
and large lipid vesicles were observed under DIC optics (Fig 13F) and Oil Red O staining
for lipids was also detected throughout the culture (Fig 13G). Gene expression analyses
also showed that the adipocyte gene markers Adiponectin, Adipsin and Perilipin were all
substantially up-regulated during differentiation (Fig 13H).
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Sorted Osterix-Cherry+ cells also retained the ability to differentiate into
chondrocytes. During chondrocyte differentiation, cells maintained their Osterix reporter
expression, but the intensity of the reporter was less compared to levels of expression
during osteoblast differentiation (Fig 13I). Under DIC optics, mesenchymal cells formed
condensations within the micromass (Fig 13J) and proteoglycan expression could be
detected by staining with Alcian Blue (Fig 13K). Gene expression analyses of
chondrocyte formation showed up-regulation of Sox9, Collagen type 2 alpha 1, and
Collagen type 10 alpha 1 (Fig 13L).
Taken together, these in vitro studies provide evidence that Osterix reporter
labeled cells from the bone marrow contribute to a stromal cell population that retains
multipotent skeletal potential.

CELL SURFACE PROFILING AND GENE EXPRESSION FROM LORE CELLS
REVEALS THEIR HETEROGENEITY
To further understand the identity and homogeneity of the bone marrow cell
population retaining Osterix reporter expression, cell surface profiling was carried out on
cells directly flushed from the bone marrow and after 5 days in culture. As previously
mentioned, between 1-2% of the total bone marrow fraction retained Osterix reporter
expression (Fig 12 J), though this can be divided into two parts based on the intensity of
the cherry expression (Fig 14, Gating Control). A variety of cell surface markers were
used including hematopoietic (CD45 and CD11b), endothelial (CD31), and mesenchymal
(CD44, Sca1, CD29, CD105, CD90.2 and CD140b).
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When profiled directly from the bone marrow, three populations of cells were
elucidated: a cherry negative fraction (blue), a cherry low population (green) and a cherry
high population (red). All cell populations have high levels of CD45 (~75-95%), CD44
(>85%) and C29 (>85%). Cherry positive cells from both groups show higher levels of
CD11b (~60%) than the negative fraction (~30%). The cherry high population has
significantly higher levels of CD31 (~85%) than either the negative (~35%) or the low
(~50%), likely due to the association of those cells with the vascular sinusoidal network.
All populations have low levels of Sca1 (<10%), CD105 (<10%) and CD140b (<5%). Of
interest is CD90, which is considered to be an MSC marker; approximately 50% of the
cherry positive cells were positive for CD90, whereas less than 5% of the cherry low or
negative cells were positive for CD90 (Fig 14).
After culturing for 5 days, the cell surface profile of the Osterix-Cherry
population significantly changed (Fig 15). Minimal CD31 expression was detected and
mesenchymal markers Sca1, CD105, and CD140b all markedly increased in the cherry
positive population. Interestingly, hematopoietic cell surface markers CD45 and CD11b
still persisted, in many cases at higher levels than initially detected directly from the
marrow. CD105 and CD140b are detected at very low levels in the negative; however
these markers are now expressed in 40% and 70% of the cherry positive cells,
respectively. CD90 expression in the cherry positive population is lost in culture.
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FIGURE 14 : CELL SURFACE PROFILING FROM THE BONE MARROW
Cells flushed from the marrow of 3-week old mice (n=3) were gated based on cherry expression into 3 groups: negative (Blue), cherry
low (Green) and cherry high(Red). Each group was analyzed for a variety of cell surface markers including CD45, CD31, CD11b,
CD44, CD29, Sca1, CD105, CD140b and CD90. The cell surface marker+ populations graph shows a typical plot, in this case, CD45,
indicating where each population falls per quadrant. Populations were analyzed and the percentage of cells in each group which was
positive for the marker was graphed.
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FIGURE 15 : CELL SURFACE PROFILE OF CULTURED BONE MARROW CELLS
Cells flushed from the marrow of 3-week old mice (n=3) were individually cultured for 5 days, then enzymatically digested and
subjected to FACS sorting. Cells were gated based on cherry expression into 2 groups: negative (blue) and cherry high (red). Each
group was analyzed for a variety of cell surface markers including CD45, CD31, CD11b, CD44, CD29, Sca1, CD105, CD140b and
CD90. The cell surface marker+ populations graph shows a typical plot, in this case, CD45, indicating where each population falls per
quadrant. Populations were analyzed and the percentage of cells in each group which was positive for the marker was graphed.

Culturing the bone marrow drastically changes the cell surface profile. The most
dramatic change is the loss of the lowest expressing cherry positive population. The
expression of cherry in the cultured cells is much more uniform than that seen directly
from the marrow. After culture, cherry positive cells lose CD90 and CD31, but gain
mesenchymal markers like Sca1, CD140b and CD105. Clearly, the environmental
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differences between the bone marrow and those seen during cell culture result in notable
changes in the cell surface
phenotype.
To try to further
determine the identity of
the Osterix-Cherry positive
cell, we also examined the
expression of Stem Cell
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Cherry Neg
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Cherry Neg

Cherry Pos

Factor (SCF) and CXCL12

FIGURE 16: UPREGULATION OF CXCL12 AND STEM CELL FACTOR IN SORTED
CHERRY POSITIVE CELLS FROM THE MARROW

in the our Osterix-Cherry

Cells directly from the marrow were sorted, RNA was extracted and cDNA was made. qPCR
was performed for CXCL12 and Stem Cell Factor. There is modest upregulation of both in the
cherry positive population as compared to the cherry negative.

sorted fraction directly from

the bone marrow, as these markers have been shown to be upregulated in the subendothelial cells in the niche that are multipotent. Osterix was increased about 30-40 fold
in the cherry positive population compared to the cherry negative population (confirming
our sort efficiency and that our reporter model is accurately marking cells expressing
Osterix (data not shown)). CxCl12 and Stem Cell Factor were both modestly upregulated
in the sorted cherry positive population compared to the cherry negative (Fig 16).
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DISCUSSION:
In this study, we have investigated a novel bone marrow cell population retaining
low Osterix reporter expression (LORE). Given the functional role of Osterix and the
location of LORE cells in proximity to endocortical bone surfaces, a reasonable
assumption is that LORE cells may represent an early osteoprogenitor cell type. In
agreement with this thinking, staining for alkaline phosphatase, an early gene marker of
osteogenesis co-localized with many LORE cells. However, further characterization of
the LORE cell population implicated that at least a subpopulation may be comparable to
bone marrow mesenchymal stem cells (BMSCs) or the multipotent perivascular stromal
cell. First, immunostaining in tissue section showed that ~43% of LORE cells associated
with the vascular sinusoids similar to other multipotent perivascular stromal cell types.
Second, gene expression levels for perivascular gene markers SCF and Cxcl12 were all
up-regulated in the Osterix-Cherry+ cell fraction compared to the negative cell fraction.
Third, a subpopulation of Osterix-Cherry+ cells were adherent to tissue culture plastic
and grew in colonies as one would expect from BMSCs [19, 20]. Finally, in vitro
differentiation of sorted Osterix-Cherry cells provided evidence for their skeletal
multipotency.
At the same time, cell surface profiling indicates that the LORE cell population is
likely to be heterogeneous. Osterix reporter labeling seems to favor higher expression of
CD11b and cells which express high levels of cherry also express high levels of CD90.
As these cells are cultured, their cell surface profile changes. The Cherry+
population loses expression of CD31, and gains expression of more mesenchymal
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markers, like CD44, CD29, Sca1, CD105 and CD140b [67, 74], with culture.
Traditionally, CD45 and CD11b are not considered to be expressed in a mesenchymal
population; however, our data shows that both markers remain high after 5 days in
culture. We are currently studying the CD45+ and the CD11b+ population to try to
determine why these markers seem to be maintained in our population. Ooi, et al.
suggested that BMSCs originally start out as CD45+ and then lose that expression over
time. [75, 76] This is similar to what we are seeing with our Cherry+ cell population.
The bone marrow is a very heterogeneous environment. Teasing out various cell
populations, even with the tools available to us, is difficult. In this study, we have
identified a small population expressing Osterix in the bone marrow that associates with
the vascular sinusoids and is ALP+. This Osterix-Cherry+ cell adheres to tissue culture
plastic and is multipotent. However, there are subpopulations within this small
population which make further characterization difficult. Multiple cell types reside on or
near the vascular sinusoidal network. These cells often display similar properties to our
Osterix-Cherry+ population. The Osterix-Cherry reporter allows us to pull apart some of
these populations based on intensity and proximity to the endocortical surface, but we
have yet to fully characterize all of the subpopulations that are reporter positive that we
see within the marrow.
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CHAPTER VI: OVERVIEW AND FUTURE DIRECTIONS:
Fluorescent reporter animal models are valuable tools to investigate biological
processes. To learn more about osteoblast biology, in this thesis, we have presented work
on the generation and characterization of Osterix-Cherry reporter mice. While the utility
of this animal model may have broad applications within the field of skeletal research,
our studies have been primarily focused in two areas. First, characterizing reporter
expression in correlation to the endogenous Osterix gene expression and secondly,
scrutinizing the identity of cell types retaining reporter expression with a particular
interest on bone marrow skeletal progenitor cells. Our Osterix reporter mice have
allowed us to tease out some of the intricacies of the Osterix gene and its regulation.

OSTERIX EXPRESSION IS NOT EXCLUSIVE TO THE OSTEOBLAST LINEAGE
The importance of Osterix for osteoblast differentiation is well established [1, 7,
44, 63, 77, 78], thus we anticipated reporter expression would be largely exclusive to
cells of the osteoblast lineage. In agreement with previous studies, Osterix reporter
expression was highly and selectively expressed in cells of the osteoblast lineage with
strong reporter expression being present in mature osteoblasts and osteocytes. However,
our studies also revealed that Osterix is also expressed in maturing chondrocytes.
Interestingly, Osterix reporter expression progressively increased in growth plate
chondrocytes with age. Consistent with these observations, recent work has validated an
essential role for Osterix in chondrocyte differentiation [62].
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In addition to the growth plate, during early postnatal life, we also detected very
robust, but transient Osterix reporter expression in the collecting ducts of the kidneys.
The timing of expression in newborn animals seemed to coincide with the onset of
suckling. Thus, while a role for Osterix in the kidney remains to be determined, we
speculate that Osterix may be involved in the regulation of calcium-phosphate
reabsorption during this very active phase of skeletal growth.

LOW OSTERIX REPORTER EXPRESSION MARKS A BONE MARROW CELL
POPULATION
While Osterix reporter expression was robustly detected in mature osteoblasts and
osteocytes, we also noted cells present within the bone marrow that retained low levels of
reporter expression. Careful examination of Osterix reporter expression by sectioning
bone tissue in cross-section revealed that low Osterix reporter cells were located in
proximity to endocortical bone surfaces. Compared to previously generated osteoblast
reporter mouse models, including Bone Sialoprotein –Topaz and Collagen 1a1 3.6–Cyan,
which had little to no expression in any bone marrow cell population, the detection of
Osterix reporter expression in a bone marrow cell population was novel.
Given the early role for Osterix in osteoblast differentiation and the proximity of
these cells adjacent to the bone surface, we hypothesized that this cell population was an
early osteoprogenitor cell population.

One of the benefits we found with this mouse is

that we have a fluorescent population within the marrow that can be FACS isolated,
allowing for careful analysis of this specific stromal population, even though it makes up
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a very small percentage (1-3%) of the marrow. Thus, our work from that point forward
sought to characterize this cell population.

OSTERIX REPORTER EXPRESSION STROMAL CELLS DISPLAY
MESENCHYMAL MULTIPOTENCY

Stromal cultures derived from Osterix reporter mice revealed that cells taken from
the bone marrow containing Osterix reporter expression directly contributed to an
adherent cell population. This was recently confirmed by FACS isolation of Osterix
reporter positive cells directly from the bone marrow and their contribution to colony
formation in co-cultures. Interestingly, in vitro differentiation studies implicate that the
Osterix reporter expressing cell population does retain multipotent properties, being able
to differentiate into osteoblasts, adipocytes, and chondrocytes, in vitro. These findings
were somewhat surprising because it is well established that functionally Osterix has an
important role in osteoblast commitment [7, 11, 41, 63]. However, consistent with our
studies, recent fate mapping studies demonstrated how embryonic progenitors labeled by
Osterix-Cre and Osterix-CreERT2 mice traced into a variety of cell types within the bone
marrow including adipocyte, perineural, vascular smooth muscle, and stromal in addition
to the osteoblast lineage[70]. Thus, low and early Osterix reporter expression potentially
identifies a cell population of osteoprogenitor cells that are not fully committed to the
osteoblast lineage and can contribute to other cell lineages.
Our studies also suggest that the post-transcriptional regulation of Osterix is likely
to be critically important for osteoblast differentiation. In this regard, some recent
studies have started to elucidate at least some of the post-transcriptional mechanisms
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which regulate Osterix function[77]. BMP2/ Smad signaling can act indirectly on
Osterix through Runx2 and Dlx5. Both of these pathways, along with the activation of the
MAPK signaling cascade will enhance the phosphorylation and thus enhance the
expression of Osterix, as does Igf1 and the Unfolded Protein Response[79-81]. TNFa
and p53 can repress the expression of Osterix by preventing its phosphorylation [3, 82].
Also, various other mechanisms, like DNA methylation and microRNAs allow for
epigenetic control of Osterix expression [83, 84]. Further studies have shown the NO66
represses phosphorylated Osterix activity and NFATc enhances the activity of
phosphorylated Osterix [85-87].

CLINICAL RELEVANCE OF OSTERIX:
Osterix has recently been implicated in a variety of skeletal diseases. Originally,
based on mouse studies, deficiencies in Osterix were thought to be lethal in humans as
well, but some recent studies by Lapunzina et al have identified a Single Nucleotide
Polymorphism (SNP) in an Egyptian Osteogenesis Imperfecta (OI) patient, producing a
truncated Osterix protein[88]. Osteogenesis Imperfecta has long been associated with
mutations in Collagen, not Osterix, so this mutation shows another potential causative
agent for OI. Genome Wide Association Studies (GWAS) have shown that SNPs in
Osterix are strongly correlated with adult lumbar spine BMD and increased BMD in
females with childhood obesity [89, 90].

Taken together, these studies show a clear

significance for Osterix in bone health[77].
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In order to study how Osterix is involved in bone disease, we could modulate
various factors: one could examine how the disease process or a potential treatment
effects cells of all stages of the osteogenic lineage based on our Cherry reporter. We
have the potential to be able to regulate Osterix in vivo and in vitro using small
molecules– looking at how agonists and antagonists of certain pathways change the
expression of the reporter.

AN UNEXPECTED CELL SURFACE PROFILE FOR OSTERIX REPORTER
EXPRESSING BONE MARROW CELLS
To more clearly define the bone marrow cell population retaining low Osterix
reporter expression, we carried out cell surface profiling directly from the bone marrow
and from day 5 stromal cultures. While the cell surface profile of osteoprogenitor cells
has not been well defined, because of their mesenchymal-like multipotency, we
speculated they might have a cell surface profile similar to previously reported bone
marrow stromal cell populations. Surprisingly, characterization directly from the bone
marrow revealed a more complex profile that included cell surface markers commonly
associated with the hematopoietic and endothelial cell lineages including CD45+,
CD11b+, and CD31+. The potential significance of hematopoietic cell marker
expression on the Osterix reporter expressing cell population remains unclear. Perhaps it
is a signature correlated with cell-cell communication occurring in the bone marrow.
Additionally, three known mesenchymal cell surface markers (CD44, CD29, and CD90)
were up-regulated in the Osterix reporter population while other mesenchymal markers
like Sca1 and CD105 and CD140b were scarcely present.
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Interestingly, transition into a cell culture environment resulted in a significant
alteration in cell surface profile more consistent with what has been previously reported
for mesenchymal stem cells. After 5 days in culture, Osterix reporter cells were Sca1+,
CD105+ and CD140b+ in addition to having very high levels of CD44 and CD29.
Surprisingly, they also retained CD45+ and CD11b+ surface markers; however the
staining intensity for these hematopoietic markers was lower than that of the negative
fraction. The alteration in cell surface profiling from the bone marrow environment to
the tissue culture environment may reflect a combination of possibilities. First, different
environments resulted in substantial changes in cell profiles. The in vivo bone marrow
environment is substantially more complex and likely to have broader diversity, whereas
the tissue culture environment is more uniform, thus similar cells will have a common
response and possibly alter their cell surface phenotype in the same manner.
Additionally, during the transition from the bone marrow environment to the cell culture
environment, a substantial selection process takes place resulting in the presence and
expansion of certain cell types over others.
The expression of cell surface markers more consistent with the myeloid lineage
(CD11b, CD115, and F4/80) on Osterix reporter cells is currently an area we are actively
investigating. It remains unclear if these are macrophages that have engulfed dead
osteoblasts and have acquired cherry fluorescence through phagocytosis or if the gene
expression of these cell surface markers remains promiscuous and crosses over into the
osteoblast lineage.
A second possibility is that a subpopulation of Osterix reporter expressing cells
are fibrocytes. Fibrocytes are mesenchymal progenitors that exhibit characteristics of
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hematopoietic stem cells, monocytes and fibroblasts [91]. These cells have a very similar
cell surface marker profile to what we are seeing in our reporter positive cells, especially
from the bone marrow. Based on the markers we tested, both our reporter positive cells
and fibrocytes are CD45+, CD11b+ and CD29+ [91, 92]. Future experiments will try to
tease out the identity of the Osterix reporter expressing cells in the marrow.

CELLULAR HETEROGENEITY AND THE BIOLOGICAL COMPLEXITY OF THE
BONE MARROW ENVIRONMENT
The bone marrow is a complex and heterogeneous environment. There are
multiple cell types and niches within the marrow itself which each have their own unique
biology and characteristics. Studies from our lab have shown that most cell types which
contribute to the structure of the stroma, maintain their niche and location within the
marrow[70]. Clearly, there is evidence that given the functional role of Osterix and the
location of Osterix–Cherry+ cells in proximity to endocortical bone surfaces, a
reasonable assumption is that these cells may represent an early osteoprogenitor cell type,
but it is also possible that progenitor cells may be reacting to signals within their local
environment such that cells which are closer to the endosteal surface take on different
characteristics then when they are in the center of the marrow. Our Osterix-Cherry+
cells are likely representing at least two subpopulations, based on reporter intensity, cell
surface profiling, immunostaining results and proximity to the bone surface. Further
studies will be necessary to elucidate the identity of each subpopulation of OsterixCherry+ cells and to characterize their distinct roles in the marrow environment and why
Osterix expression is needed for these cell types.
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